Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended | |
Dec. 31, 2013 | Jan. 31, 2014 | |
Document and Entity Information [Abstract] | ' | ' |
Document Type | '10-Q | ' |
Amendment Flag | 'false | ' |
Document Period End Date | 31-Dec-13 | ' |
Document Fiscal Year Focus | '2014 | ' |
Document Fiscal Period Focus | 'Q1 | ' |
Trading Symbol | 'NUAN | ' |
Entity Registrant Name | 'Nuance Communications, Inc. | ' |
Entity Central Index Key | '0001002517 | ' |
Current Fiscal Year End Date | '--09-30 | ' |
Entity Filer Category | 'Large Accelerated Filer | ' |
Entity Common Stock, Shares Outstanding | ' | 317,158,481 |
CONSOLIDATED_STATEMENTS_OF_OPE
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) | 3 Months Ended | |
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Revenues: | ' | ' |
Product and licensing | $178,437 | $196,731 |
Professional services and hosting | 218,135 | 200,305 |
Maintenance and support | 73,408 | 65,232 |
Total revenues | 469,980 | 462,268 |
Cost of revenues: | ' | ' |
Product and licensing | 25,438 | 26,309 |
Professional services and hosting | 154,580 | 125,156 |
Maintenance and support | 12,608 | 14,797 |
Amortization of intangible assets | 15,194 | 16,310 |
Total cost of revenues | 207,820 | 182,572 |
Gross profit | 262,160 | 279,696 |
Operating expenses: | ' | ' |
Research and development | 80,470 | 68,721 |
Sales and marketing | 118,906 | 117,135 |
General and administrative | 44,476 | 44,784 |
Amortization of intangible assets | 27,472 | 25,426 |
Acquisition-related costs, net | 2,798 | 15,733 |
Restructuring and other charges, net | 3,837 | 1,667 |
Total operating expenses | 277,959 | 273,466 |
(Loss) income from operations | -15,799 | 6,230 |
Other income (expense): | ' | ' |
Interest income | 419 | 538 |
Interest expense | -33,959 | -34,117 |
Other expense, net | -3,096 | -3,308 |
Loss before income taxes | -52,435 | -30,657 |
Provision (benefit) from income taxes | 2,978 | -8,561 |
Net loss | ($55,413) | ($22,096) |
Net loss per share: | ' | ' |
Basic (in dollars per share) | ($0.18) | ($0.07) |
Diluted (in dollars per share) | ($0.18) | ($0.07) |
Weighted average common shares outstanding: | ' | ' |
Basic (in shares) | 314,818 | 312,571 |
Diluted (in shares) | 314,818 | 312,571 |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Net loss | ($55,413) | ($22,096) |
Other comprehensive income: | ' | ' |
Foreign currency translation adjustment | 6,604 | 7,111 |
Defined Benefit Plan, Amortization of Gains (Losses) | 0 | 133 |
Total other comprehensive income, net | 6,604 | 7,244 |
Comprehensive loss | ($48,809) | ($14,852) |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Dec. 31, 2013 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Current assets: | ' | ' |
Cash and cash equivalents | $734,656 | $808,118 |
Available-for-sale Securities, Current | 40,440 | 38,728 |
Accounts receivable, less allowances for doubtful accounts of $8,634 and $8,529 | 396,834 | 382,741 |
Prepaid expenses and other current assets | 113,534 | 104,971 |
Deferred tax asset | 75,211 | 74,969 |
Total current assets | 1,360,675 | 1,409,527 |
Land, building and equipment, net | 142,971 | 143,465 |
Goodwill | 3,350,371 | 3,293,198 |
Intangible assets, net | 954,309 | 953,278 |
Other assets | 177,387 | 159,135 |
Total assets | 5,985,713 | 5,958,603 |
Current liabilities: | ' | ' |
Current portion of long-term debt | 248,518 | 246,040 |
Accounts payable | 59,120 | 91,016 |
Accrued expenses and other current liabilities | 227,182 | 214,425 |
Deferred revenue | 301,049 | 253,753 |
Total current liabilities | 835,869 | 805,234 |
Long-term debt | 2,112,759 | 2,108,091 |
Deferred revenue, net of current portion | 183,205 | 160,823 |
Deferred tax liability | 183,728 | 162,774 |
Other liabilities | 61,532 | 83,667 |
Total liabilities | 3,377,093 | 3,320,589 |
Commitments and contingencies | ' | ' |
Stockholders’ equity: | ' | ' |
Common stock, $0.001 par value; 560,000 shares authorized; 321,035 and 319,365 shares issued and 317,284 and 315,614 shares outstanding, respectively | 321 | 319 |
Additional paid-in capital | 3,044,837 | 3,017,074 |
Treasury stock, at cost (3,751 shares) | -16,788 | -16,788 |
Accumulated other comprehensive income | 13,417 | 6,813 |
Accumulated deficit | -433,167 | -369,404 |
Total stockholders’ equity | 2,608,620 | 2,638,014 |
Total liabilities and stockholders’ equity | $5,985,713 | $5,958,603 |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Dec. 31, 2013 | Sep. 30, 2013 |
In Thousands, except Per Share data, unless otherwise specified | ||
Accounts receivable, allowances for doubtful accounts | $8,634 | $8,529 |
Common stock, par value | $0.00 | $0.00 |
Common stock, shares authorized | 560,000 | 560,000 |
Common stock, shares issued | 321,035 | 319,365 |
Common stock, shares outstanding | 317,284 | 315,614 |
Treasury stock, shares | 3,751 | 3,751 |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Cash flows from operating activities: | ' | ' |
Net loss | ($55,413) | ($22,096) |
Adjustments to reconcile net loss to net cash provided by operating activities: | ' | ' |
Depreciation and amortization | 55,109 | 50,429 |
Stock-based compensation | 47,239 | 45,271 |
Non-cash interest expense | 9,661 | 9,986 |
Deferred tax benefit | -1,612 | -4,077 |
Other | -6,150 | -1,925 |
Changes in operating assets and liabilities, net of effects from acquisitions: | ' | ' |
Accounts receivable | -6,532 | 8,815 |
Prepaid expenses and other assets | -11,095 | -9,104 |
Accounts payable | -28,032 | -18,692 |
Accrued expenses and other liabilities | 7,452 | 9,241 |
Deferred revenue | 67,529 | 55,100 |
Net cash provided by operating activities | 78,156 | 122,948 |
Cash flows from investing activities: | ' | ' |
Capital expenditures | -14,166 | -15,104 |
Payments for business and technology acquisitions, net of cash acquired | -99,496 | -446,192 |
Payments to Acquire Investments | 5,063 | 0 |
Proceeds from sales and maturities of marketable securities and other investments | 13,372 | 456 |
Net cash used in investing activities | -105,353 | -460,840 |
Cash flows from financing activities: | ' | ' |
Payments of debt | -1,307 | -144,835 |
Proceeds from long-term debt, net of issuance costs | 0 | 352,611 |
Payments for repurchase of common stock | -18,000 | 0 |
Payments for settlement of share-based derivatives | -1,032 | -177 |
Proceeds from (Payments for) Other Financing Activities | -904 | -1,012 |
Excess tax benefits on employee equity awards | 0 | 4,974 |
Proceeds from issuance of common stock from employee stock plans | 1,188 | 1,906 |
Cash used to net share settle employee equity awards | -26,506 | -43,859 |
Net cash (used in) provided by financing activities | -46,561 | 169,608 |
Effects of exchange rate changes on cash and cash equivalents | 296 | -389 |
Net decrease in cash and cash equivalents | -73,462 | -168,673 |
Cash and cash equivalents at beginning of period | 808,118 | 1,129,761 |
Cash and cash equivalents at end of period | $734,656 | $961,088 |
Organization_and_Presentation
Organization and Presentation | 3 Months Ended |
Dec. 31, 2013 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Organization and Presentation | ' |
Organization and Presentation | |
The consolidated financial statements include the accounts of Nuance Communications, Inc. (“Nuance”, “we”, or “the Company”) and our wholly-owned subsidiaries. We prepared these unaudited interim consolidated financial statements in accordance with U.S. generally accepted accounting principles (GAAP) for interim periods. In our opinion, these financial statements reflect all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of our financial position for the periods disclosed. Intercompany transactions have been eliminated. | |
We reclassified certain immaterial amounts between product and licensing and maintenance and support revenues previously reported for the three months ended December 31, 2012. The reclassifications have no impact on earnings or cash flows provided by operations. | |
Although we believe the disclosures in these financial statements are adequate to make the information presented not misleading, certain information normally included in the footnotes prepared in accordance with GAAP has been omitted. Accordingly, these financial statements should be read in conjunction with the audited financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2013. Interim results are not necessarily indicative of the results that may be expected for a full year. |
Summary_of_Significant_Account
Summary of Significant Accounting Policies | 3 Months Ended |
Dec. 31, 2013 | |
Accounting Policies [Abstract] | ' |
Summary of Significant Accounting Policies | ' |
Summary of Significant Accounting Policies | |
Effective October 1, 2013, we implemented Accounting Standards Update No. 2013-02, Comprehensive Income (Topic 220) — Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, which did not have a significant impact on our consolidated financial statements. | |
We have made no material changes to the significant accounting policies disclosed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2013. | |
Recently Issued Accounting Standards | |
In July 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists" (ASU 2013-11) to provide guidance on the presentation of unrecognized tax benefits. ASU 2013-11 requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows: to the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. ASU 2013-11 is effective for us in our first quarter of fiscal 2015 with earlier adoption permitted. ASU 2013-11 should be applied prospectively with retroactive application permitted. We do not believe that this will have a material impact on our consolidated financial statements. |
Business_Acquisitions
Business Acquisitions | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Business Combinations [Abstract] | ' | |||||||
Business Acquisitions | ' | |||||||
Business Acquisitions | ||||||||
Fiscal 2014 Acquisitions | ||||||||
During fiscal 2014, we acquired several businesses for total cash consideration of $101.0 million. In allocating the total purchase consideration for these acquisitions based on preliminary estimated fair values, we recorded $51.9 million of goodwill and $42.5 million of identifiable intangibles assets. Intangible assets acquired included customer relationships and core and completed technology with weighted average useful lives of 10.0 years. These acquisitions are not individually material and were made in our Healthcare and Enterprise segments. These acquisitions are treated as stock purchases, and the goodwill resulting from these acquisitions is not expected to be deductible for tax purposes. | ||||||||
Pro Forma Results | ||||||||
On May 31, 2013, we acquired the Technology Solutions Segment ("TGT") of the Tweddle Group for total consideration of $83.3 million in cash, including a purchase price adjustment as specified in the asset purchase agreement. TGT provides cloud-based infotainment and communications solutions to the automotive industry. The transaction was structured as an asset acquisition, and therefore the goodwill is expected to be deductible for tax purposes. The results of operations for TGT are included in our Mobile and Consumer segment from the acquisition date. | ||||||||
The following table shows unaudited pro forma results of operations as if we had acquired TGT on October 1, 2012 (dollars in thousands, except per share amounts): | ||||||||
Three Months Ended December 31, | ||||||||
2013 | 2012 | |||||||
Revenue | $ | 469,980 | $ | 464,364 | ||||
Net loss | (55,413 | ) | (25,669 | ) | ||||
Net loss per share - diluted | $ | (0.18 | ) | $ | (0.08 | ) | ||
We have not furnished pro forma financial information related to our other recent acquisitions because such information is not material, individually or in the aggregate, to our financial results. The unaudited pro forma results of operations are not necessarily indicative of the actual results that would have occurred had the transactions actually taken place at the beginning of the periods indicated. | ||||||||
Acquisition-Related Costs, net | ||||||||
Acquisition-related costs include costs related to business and other acquisitions, including potential acquisitions. These costs consist of (i) transition and integration costs, including retention payments, transitional employee costs and earn-out payments treated as compensation expense, as well as the costs of integration-related activities including services provided by third-parties; (ii) professional service fees, including third party costs related to the acquisitions, and legal and other professional service fees associated with disputes and regulatory matters related to acquired entities; and (iii) adjustments to acquisition-related items that are required to be marked to fair value each reporting period, such as contingent consideration, and other items related to acquisitions for which the measurement period has ended. | ||||||||
The components of acquisition-related costs, net are as follows (dollars in thousands): | ||||||||
Three Months Ended December 31, | ||||||||
2013 | 2012 | |||||||
Transition and integration costs | $ | 3,839 | $ | 6,263 | ||||
Professional service fees | 3,339 | 9,470 | ||||||
Acquisition-related adjustments | (4,380 | ) | — | |||||
Total | $ | 2,798 | $ | 15,733 | ||||
Included in acquisition-related adjustments for the three months ended December 31, 2013, is income of $7.7 million related to the elimination of a contingent liability established in the original allocation of purchase price for an acquisition closed in fiscal 2008, following the expiration of the applicable statute of limitations. As a result, we have eliminated the contingent liability, and included the adjustment in acquisition-related costs, net in our consolidated statements of operations. |
Contingent_Acquisition_Payment
Contingent Acquisition Payments | 3 Months Ended | |
Dec. 31, 2013 | ||
Disclosure Contingent Acquisition Payments Additional Information [Abstract] | ' | |
Contingent Acquisition Payments | ' | |
Contingent Acquisition Payments | ||
The fair value of any contingent consideration is established at the acquisition date and included in the total purchase price. The contingent consideration is then adjusted to fair value as an increase or decrease in current earnings included in acquisition-related costs, net in each reporting period. | ||
In connection with our acquisition of JA Thomas in October 2012, we agreed to make deferred payments to the former shareholders of JA Thomas of up to $25.0 million in October 2014, contingent upon the continued employment of certain named executives and certain other conditions. The contingent payments will be reduced by amounts specified in the merger agreement in the event that any of the named executives terminates their employment prior to the payment date. The portion of the deferred payment that is payable to the named executives is being recognized as compensation expense over the two year employment period and included in acquisition-related costs, net in our consolidated statement of operations. |
Goodwill_and_Intangible_Assets
Goodwill and Intangible Assets | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | |||||||
Goodwill and Intangible Assets | ' | |||||||
Goodwill and Intangible Assets | ||||||||
The changes in the carrying amount of goodwill and intangible assets for the three months ended December 31, 2013, are as follows (dollars in thousands): | ||||||||
Goodwill | Intangible | |||||||
Assets | ||||||||
Balance at September 30, 2013 | $ | 3,293,198 | $ | 953,278 | ||||
Acquisitions | 51,871 | 43,409 | ||||||
Purchase accounting adjustments | 542 | (59 | ) | |||||
Amortization | — | (42,666 | ) | |||||
Effect of foreign currency translation | 4,760 | 347 | ||||||
Balance at December 31, 2013 | $ | 3,350,371 | $ | 954,309 | ||||
Financial_Instruments_and_Hedg
Financial Instruments and Hedging Activities | 3 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ||||||||||
Financial Instruments and Hedging Activities | ' | ||||||||||
Financial Instruments and Hedging Activities | |||||||||||
Derivatives Not Designated as Hedges | |||||||||||
Forward Currency Contracts | |||||||||||
We operate our business in countries throughout the world and transact business in various foreign currencies. Our foreign currency exposures typically arise from transactions denominated in currencies other than the functional currency of our operations. We have a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effect of certain foreign currency exposures. Our program is designed so that increases or decreases in our foreign currency exposures are offset by gains or losses on the foreign currency forward contracts in order to mitigate the risks and volatility associated with our foreign currency transactions. Generally we enter into contracts for less than 90 days, and at December 31, 2013 and September 30, 2013, we had outstanding contracts with a total notional value of $330.8 million and $247.8 million, respectively. | |||||||||||
We have not designated these forward contracts as hedging instruments pursuant to ASC 815, Derivatives and Hedging, and accordingly, we record the fair value of these contracts at the end of each reporting period in our consolidated balance sheet, with changes in the fair value recorded in earnings as other expense, net in our consolidated statements of operations. | |||||||||||
Security Price Guarantees | |||||||||||
From time to time we enter into agreements that allow us to issue shares of our common stock as part or all of the consideration related to partnering and technology acquisition activities. Generally these shares are issued subject to security price guarantees, which are accounted for as derivatives. We have determined that these instruments would not be considered equity instruments if they were freestanding. The security price guarantees require payment from either us to a third party, or from a third party to us, based upon the difference between the price of our common stock on the issue date and an average price of our common stock approximately six months following the issue date. Changes in the fair value of these security price guarantees are reported in earnings in each period as other expense, net in our consolidated statements of operations. | |||||||||||
The following is a summary of the outstanding shares subject to security price guarantees at December 31, 2013 (dollars in thousands): | |||||||||||
Issue Date | Number of Shares Issued | Settlement Date | Total Value of Shares | ||||||||
on Issue Date | |||||||||||
August 15, 2013 | 934,960 | February 15, 2014 | $ | 18,400 | |||||||
The following table provides a quantitative summary of the fair value of our derivative instruments as of December 31, 2013 and September 30, 2013 (dollars in thousands): | |||||||||||
Derivatives Not Designated as Hedges: | Balance Sheet Classification | Fair Value | |||||||||
31-Dec-13 | 30-Sep-13 | ||||||||||
Foreign currency contracts | Prepaid expenses and other current assets | $ | 949 | $ | 2,201 | ||||||
Security Price Guarantees | Accrued expenses and other current liabilities | (4,182 | ) | (1,044 | ) | ||||||
Net fair value of non-hedge derivative instruments | $ | (3,233 | ) | $ | 1,157 | ||||||
The following tables summarize the activity of derivative instruments for the three months ended December 31, 2013 and 2012 (dollars in thousands): | |||||||||||
Amount of Gain (Loss) Recognized in Income | |||||||||||
Derivatives Not Designated as Hedges | Location of Gain (Loss) Recognized in Income | 2013 | 2012 | ||||||||
Foreign currency contracts | Other expense, net | $ | 1,963 | $ | (104 | ) | |||||
Security price guarantees | Other expense, net | $ | (4,150 | ) | $ | (2,510 | ) | ||||
Other Financial Instruments | |||||||||||
Financial instruments, including cash equivalents, marketable securities, accounts receivable, accounts payable, and derivative instruments, are carried in the consolidated financial statements at amounts that approximate their fair value. | |||||||||||
The estimated fair value of our long-term debt approximated $2,431.5 million (face value $2,471.0 million) and $2,458.2 million (face value $2,472.2 million) at December 31, 2013 and September 30, 2013, respectively. These fair value amounts represent the value at which our lenders could trade our debt within the financial markets, and do not represent the settlement value of these long-term debt liabilities to us at each reporting date. The fair value of the long-term debt issues will continue to vary each period based on fluctuations in market interest rates, as well as changes to our credit ratings. The Senior Notes, the term loan portion of our Credit Facility, and the Convertible Debentures are traded and the fair values are based upon trading prices as of the reporting dates. The fair values of each borrowing was estimated using the averages of the bid and ask trading quotes at each respective date. We had no outstanding balance on the revolving credit line portion of our Credit Facility at December 31, 2013 and September 30, 2013. |
Fair_Value_Measures
Fair Value Measures | 3 Months Ended | |||||||||||||||
Dec. 31, 2013 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||
Fair Value Measures | ' | |||||||||||||||
Fair Value Measures | ||||||||||||||||
Fair value is defined as the price that would be received for an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. Valuation techniques must maximize the use of observable inputs and minimize the use of unobservable inputs. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and consider assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. | ||||||||||||||||
ASC 820, Fair Value Measures and Disclosures, establishes a value hierarchy based on three levels of inputs, of which the first two are considered observable and the third is considered unobservable: | ||||||||||||||||
• | Level 1. Quoted prices for identical assets or liabilities in active markets which we can access. | |||||||||||||||
• | Level 2. Observable inputs other than those described as Level 1. | |||||||||||||||
• | Level 3. Unobservable inputs. | |||||||||||||||
Items measured at Fair Value on a Recurring Basis | ||||||||||||||||
Assets and liabilities measured at fair value on a recurring basis at December 31, 2013 and September 30, 2013 consisted of (dollars in thousands): | ||||||||||||||||
31-Dec-13 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: | ||||||||||||||||
Money market funds(a) | $ | 617,061 | $ | — | $ | — | $ | 617,061 | ||||||||
US government agency securities(a) | 1,000 | — | — | 1,000 | ||||||||||||
Marketable securities, $40,440 at cost (b) | — | 40,440 | — | 40,440 | ||||||||||||
Foreign currency exchange contracts(b) | — | 949 | — | 949 | ||||||||||||
Total assets at fair value | $ | 618,061 | $ | 41,389 | $ | — | $ | 659,450 | ||||||||
Liabilities: | ||||||||||||||||
Security price guarantees(c) | $ | — | $ | (4,182 | ) | $ | — | $ | (4,182 | ) | ||||||
Contingent earn-out(d) | — | — | (1,319 | ) | (1,319 | ) | ||||||||||
Total liabilities at fair value | $ | — | $ | (4,182 | ) | $ | (1,319 | ) | $ | (5,501 | ) | |||||
30-Sep-13 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: | ||||||||||||||||
Money market funds(a) | $ | 684,697 | $ | — | $ | — | $ | 684,697 | ||||||||
US government agency securities(a) | 1,000 | — | — | 1,000 | ||||||||||||
Marketable securities, $38,728 at cost (b) | — | 38,728 | — | 38,728 | ||||||||||||
Foreign currency exchange contracts(b) | — | 2,201 | — | 2,201 | ||||||||||||
Total assets at fair value | $ | 685,697 | $ | 40,929 | $ | — | $ | 726,626 | ||||||||
Liabilities: | ||||||||||||||||
Security price guarantees(c) | $ | — | $ | (1,044 | ) | $ | — | $ | (1,044 | ) | ||||||
Contingent earn-out(d) | — | — | (450 | ) | (450 | ) | ||||||||||
Total liabilities at fair value | $ | — | $ | (1,044 | ) | $ | (450 | ) | $ | (1,494 | ) | |||||
(a) | Money market funds and U.S. government agency securities, included in cash and cash equivalents in the accompanying balance sheets, are valued at quoted market prices in active markets. | |||||||||||||||
(b) | The fair values of our time deposits, marketable securities and foreign currency exchange contracts are based on the most recent observable inputs for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable. | |||||||||||||||
(c) | The fair values of the security price guarantees are determined using a modified Black-Scholes model, derived from observable inputs such as U.S. treasury interest rates, our common stock price, and the volatility of our common stock. The valuation model values both the put and call components of the guarantees simultaneously, with the net value of those components representing the fair value of each instrument. | |||||||||||||||
(d) | The fair value of our contingent consideration arrangements are determined based on our evaluation as to the probability and amount of any earn-out that will be achieved based on expected future performance by the acquired entity. | |||||||||||||||
The changes in the fair value of contingent earn-out liabilities are as follows (dollars in thousands): | ||||||||||||||||
Three Months Ended December 31, | ||||||||||||||||
2013 | ||||||||||||||||
Balance at beginning of period | $ | 450 | ||||||||||||||
Earn-out liability established at time of acquisition | 869 | |||||||||||||||
Balance at end of period | $ | 1,319 | ||||||||||||||
Earn-out payments are payable based on achieving the specified performance criteria during defined post-acquisition time periods in accordance with the purchase and sale agreement for each acquisition. |
Accrued_Expenses_and_Other_Cur
Accrued Expenses and Other Current Liabilities | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Payables and Accruals [Abstract] | ' | |||||||
Accrued Expenses and Other Current Liabilities | ' | |||||||
Accrued Expenses and Other Current Liabilities | ||||||||
Accrued expenses and other current liabilities consisted of the following (dollars in thousands): | ||||||||
31-Dec-13 | 30-Sep-13 | |||||||
Compensation | $ | 91,875 | $ | 112,756 | ||||
Acquisition costs and liabilities | 31,546 | 15,722 | ||||||
Accrued interest payable | 27,005 | 15,879 | ||||||
Cost of revenue related liabilities | 18,600 | 17,992 | ||||||
Professional fees | 15,881 | 17,682 | ||||||
Sales and marketing incentives | 12,803 | 11,681 | ||||||
Sales and other taxes payable | 11,980 | 10,625 | ||||||
Other | 17,492 | 12,088 | ||||||
Total | $ | 227,182 | $ | 214,425 | ||||
Deferred_Revenue
Deferred Revenue | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Deferred Revenue [Abstract] | ' | |||||||
Deferred Revenue | ' | |||||||
Deferred Revenue | ||||||||
Deferred revenue consisted of the following (dollars in thousands): | ||||||||
31-Dec-13 | 30-Sep-13 | |||||||
Current Liabilities: | ||||||||
Deferred maintenance revenue | $ | 136,552 | $ | 134,213 | ||||
Unearned revenue | 164,497 | 119,540 | ||||||
Total current deferred revenue | $ | 301,049 | $ | 253,753 | ||||
Long-term Liabilities: | ||||||||
Deferred maintenance revenue | $ | 58,312 | $ | 51,784 | ||||
Unearned revenue | 124,893 | 109,039 | ||||||
Total long-term deferred revenue | $ | 183,205 | $ | 160,823 | ||||
Deferred maintenance revenue consists of prepaid fees received for post-contract customer support for our products, including telephone support and the right to receive unspecified upgrades/enhancements on a when-and-if-available basis. Unearned revenue includes upfront fees for setup and implementation activities related to hosted offerings; certain software arrangements for which we do not have fair value of post-contract customer support, resulting in ratable revenue recognition for the entire arrangement on a straight-line basis; and fees in excess of estimated earnings on percentage-of-completion service contracts. | ||||||||
The increase in unearned revenue is primarily driven by the timing of a large annual prepayment from a Healthcare customer that will be amortized over the one year service period, as well as an increase in Mobile deferred revenue related to growth in our automotive connected services for which the revenue recognition period extends over the service period. |
Restructuring_and_Other_Charge
Restructuring and Other Charges, net | 3 Months Ended | |||||||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | ' | |||||||||||||||||||||||
Restructuring and Other Charges, net | ' | |||||||||||||||||||||||
Restructuring and Other Charges, net | ||||||||||||||||||||||||
Restructuring and other charges, net include restructuring expenses together with other expenses that are unusual in nature and are the result of unplanned events, and arise outside of the ordinary course of continuing operations. Restructuring expenses consist of employee severance costs and may also include charges for duplicate facilities and other contract termination costs. Other amounts may include gains or losses on non-controlling strategic equity interests, and gains or losses on sales of non-strategic assets or product lines. The following table sets forth accrual activity relating to our restructuring reserves for the three months ended December 31, 2013 (dollars in thousands): | ||||||||||||||||||||||||
Personnel | Facilities | Total | ||||||||||||||||||||||
Balance at September 30, 2013 | $ | 4,230 | $ | 1,191 | $ | 5,421 | ||||||||||||||||||
Restructuring charges, net | 1,419 | 2,418 | 3,837 | |||||||||||||||||||||
Non-cash adjustments | 80 | 761 | 841 | |||||||||||||||||||||
Cash payments | (3,261 | ) | (607 | ) | (3,868 | ) | ||||||||||||||||||
Balance at December 31, 2013 | $ | 2,468 | $ | 3,763 | $ | 6,231 | ||||||||||||||||||
Restructuring charges, net by segment are as follows (dollars in thousands): | ||||||||||||||||||||||||
Three Months Ended December 31, | ||||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||
Personnel | Facilities | Total | Personnel | Facilities | Total | |||||||||||||||||||
Healthcare | $ | 214 | $ | — | $ | 214 | $ | 653 | $ | 558 | $ | 1,211 | ||||||||||||
Mobile and Consumer | 202 | — | 202 | 1,099 | — | 1,099 | ||||||||||||||||||
Enterprise | 177 | — | 177 | — | — | — | ||||||||||||||||||
Imaging | — | — | — | 822 | — | 822 | ||||||||||||||||||
Corporate | 826 | 2,418 | 3,244 | 143 | — | 143 | ||||||||||||||||||
Total restructuring expense | $ | 1,419 | $ | 2,418 | $ | 3,837 | $ | 2,717 | $ | 558 | $ | 3,275 | ||||||||||||
For the three months ended December 31, 2013, we recorded net restructuring charges of $3.8 million, which included a $1.4 million severance charge related to the elimination of approximately 20 personnel across multiple functions, and $2.4 million resulting from the restructuring of a facility that will no longer be utilized. |
Debt_and_Credit_Facilities
Debt and Credit Facilities | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Debt Disclosure [Abstract] | ' | |||||||
Debt and Credit Facilities | ' | |||||||
Debt and Credit Facilities | ||||||||
At December 31, 2013 and September 30, 2013, we had the following borrowing obligations (dollars in thousands): | ||||||||
31-Dec-13 | 30-Sep-13 | |||||||
5.375% Senior Notes due 2020, net of unamortized premium of $5.2 million and $5.4 million, respectively. Effective interest rate 5.28%. | $ | 1,055,190 | $ | 1,055,385 | ||||
2.75% Convertible Debentures due 2031, net of unamortized discount of $107.5 million and $113.5 million, respectively. Effective interest rate 7.43%. | 582,529 | 576,524 | ||||||
2.75% Convertible Debentures due 2027, net of unamortized discount of $6.3 million and $8.8 million, respectively. Effective interest rate 7.30%. | 243,683 | 241,206 | ||||||
Credit Facility, net of unamortized discount of $1.1 million and $1.2 million, respectively. | 479,875 | 481,016 | ||||||
Total long-term debt | $ | 2,361,277 | $ | 2,354,131 | ||||
Less: current portion | 248,518 | 246,040 | ||||||
Non-current portion of long-term debt | $ | 2,112,759 | $ | 2,108,091 | ||||
2.75% Convertible Debentures due 2031 | ||||||||
As of December 31, 2013 and September 30, 2013, none of the conversion criteria were met for the 2031 Debentures. If the conversion criteria were met, we could be required to repay all or some of the principal amount in cash prior to maturity. | ||||||||
2.75% Convertible Debentures due 2027 | ||||||||
The 2027 Debentures are puttable at the holders option in August 2014. As a result, we have classified the obligation in current liabilities at December 31, 2013 and September 30, 2013. | ||||||||
Credit Facility | ||||||||
The Credit Facility includes a term loan and a $75 million revolving credit line, including letters of credit. The term loan matures on August 7, 2019 and the revolving credit line matures on August 7, 2018. As of December 31, 2013, there were $7.2 million of letters of credit issued, and there were no other outstanding borrowings under the revolving credit line. | ||||||||
Under terms of the amended and restated credit agreement, interest is payable monthly at a rate equal to the applicable margin plus, at our option, either (a) the base rate which is the corporate base rate of Morgan Stanley, the Administrative Agent, or (b) LIBOR (equal to (i) the British Bankers’ Association Interest Settlement Rates for deposits in U.S. dollars divided by (ii) one minus the statutory reserves applicable to such borrowing). The applicable margin for the borrowings at December 31, 2013 is as follows: | ||||||||
Description | Base Rate Margin | LIBOR Margin | ||||||
Term loans maturing August 2019 | 1.75% | 2.75% | ||||||
Revolving facility due August 2018 | 0.50% - 0.75% (a) | 1.50% - 1.75% (a) | ||||||
(a) | The margin is determined based on our net leverage ratio at the date the interest rates are reset on the revolving credit line. | |||||||
At December 31, 2013 the applicable margin for the term loans was 2.75%, with an effective rate of 2.92%, on the outstanding balance of $481.0 million maturing in August 2019. We are required to pay a commitment fee for unutilized commitments under the revolving credit facility at a rate ranging from 0.375% to 0.50% per annum, based upon our net leverage ratio. As of December 31, 2013, the commitment fee rate was 0.375%. | ||||||||
The Credit Facility contains the most restrictive covenants of our long-term debt, including, among other things, covenants that restrict our ability and those of our subsidiaries to incur certain additional indebtedness or issue guarantees, create or permit liens on assets, enter into sale-leaseback transactions, make loans or investments, sell assets, make certain acquisitions, pay dividends, or repurchase stock, or merge or consolidate with any entity, and limits transactions with affiliates. The agreement also contains events of default, including failure to make payments of principal or interest, failure to observe covenants, breaches of representations and warranties, defaults under certain other material indebtedness, failure to satisfy material judgments, a change of control and certain insolvency events. As of December 31, 2013, we were in compliance with the covenants under the Credit Facility. The covenants on our other long-term debt are less restrictive, and we have met these requirements. | ||||||||
Our obligations under the Credit Facility are unconditionally guaranteed by, subject to certain exceptions, each of our existing and future direct and indirect wholly-owned domestic subsidiaries. The Credit Facility and the guarantees thereof are secured by first priority liens and security interests in the following: 100% of the capital stock of substantially all of our domestic subsidiaries and 65% of the outstanding voting equity interests and 100% of the non-voting equity interests of first-tier foreign subsidiaries, all our material tangible and intangible assets and those of the guarantors, and any present and future intercompany debt. The Credit Facility also contains provisions for mandatory prepayments of outstanding term loans upon receipt of the following, and subject to certain exceptions: 100% of net cash proceeds from asset sales, 100% of net cash proceeds from issuance or incurrence of debt, and 100% of extraordinary receipts. We may voluntarily prepay borrowings under the Credit Facility without premium or penalty other than breakage costs, as defined with respect to LIBOR-based loans. | ||||||||
The Credit Facility includes a provision for an annual excess cash flow sweep, as defined in the agreement, payable in the first quarter of each fiscal year, based on the excess cash flow generated in the previous fiscal year. No excess cash flow sweep was required in the first quarter of fiscal 2014 as no excess cash flow, as defined in the agreement was generated in fiscal 2013. At the current time, we are unable to predict the amount of the outstanding principal, if any, that we may be required to repay in future fiscal years pursuant to the excess cash flow sweep provisions. |
Stockholders_Equity_Notes
Stockholders' Equity (Notes) | 3 Months Ended |
Dec. 31, 2013 | |
Stockholders' Equity Attributable to Parent [Abstract] | ' |
Stockholders' Equity Note Disclosure [Text Block] | ' |
Stockholders' Equity | |
Stock Repurchases | |
On April 29, 2013, our Board of Directors approved a share repurchase program for up to $500 million of our outstanding shares of common stock. Approximately $295.9 million remained available for stock repurchases as of December 31, 2013 pursuant to our stock repurchase program. We repurchased 1.2 million shares for $19.7 million during the three months ended December 31, 2013 (including 0.1 million shares for $1.7 million that were repurchased, but not settled at December 31, 2013). Under the terms of the repurchase program, we expect to continue to repurchase shares from time to time through a variety of methods, which may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The timing and the amount of any purchases will be determined by management based on an evaluation of market conditions, capital allocation alternatives, and other factors. The share repurchase program does not require us to acquire any specific number of shares and may be modified, suspended, extended or terminated by us at any time without prior notice. |
Net_Loss_Income_Per_Share
Net (Loss) Income Per Share | 3 Months Ended | |||
Dec. 31, 2013 | ||||
Earnings Per Share, Basic and Diluted [Abstract] | ' | |||
Net (Loss) Income Per Share | ' | |||
Net Loss Per Share | ||||
Common equivalent shares are excluded from the computation of diluted net loss per share if their effect is anti-dilutive. Potentially dilutive common equivalent shares aggregating to 13.7 million and 14.8 million shares for the three months ended December 31, 2013 and 2012, respectively, have been excluded from the computation of diluted net loss per share because their inclusion would be anti-dilutive. | ||||
StockBased_Compensation
Stock-Based Compensation | 3 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
Share-based Compensation [Abstract] | ' | ||||||||||||
Stock-Based Compensation | ' | ||||||||||||
Stock-Based Compensation | |||||||||||||
We recognize stock-based compensation expense over the requisite service period. Our share-based awards are accounted for as equity instruments. The amounts included in the consolidated statements of operations relating to stock-based compensation are as follows (dollars in thousands): | |||||||||||||
Three Months Ended December 31, | |||||||||||||
2013 | 2012 | ||||||||||||
Cost of product and licensing | $ | 265 | $ | 185 | |||||||||
Cost of professional services and hosting | 6,619 | 2,403 | |||||||||||
Cost of maintenance and support | 784 | 2,103 | |||||||||||
Research and development | 10,288 | 8,860 | |||||||||||
Selling and marketing | 15,244 | 16,847 | |||||||||||
General and administrative | 14,039 | 14,873 | |||||||||||
Total | $ | 47,239 | $ | 45,271 | |||||||||
Stock Options | |||||||||||||
The table below summarizes activity relating to stock options for the three months ended December 31, 2013: | |||||||||||||
Number of | Weighted | Weighted | Aggregate | ||||||||||
Shares | Average | Average | Intrinsic | ||||||||||
Exercise | Remaining | Value(a) | |||||||||||
Price | Contractual | ||||||||||||
Term | |||||||||||||
Outstanding at September 30, 2013 | 4,184,158 | $ | 13.08 | ||||||||||
Exercised | (140,260 | ) | $ | 8.47 | |||||||||
Forfeited | (974 | ) | $ | 20.04 | |||||||||
Expired | (2,393 | ) | $ | 17.46 | |||||||||
Outstanding at December 31, 2013 | 4,040,531 | $ | 13.23 | 2.7 years | $ | 9.8 | million | ||||||
Exercisable at December 31, 2013 | 4,019,980 | $ | 13.23 | 2.7 years | $ | 9.7 | million | ||||||
Exercisable at December 31, 2012 | 5,715,146 | $ | 11.54 | 2.9 years | $ | 61.6 | million | ||||||
(a) | The aggregate intrinsic value in this table was calculated based on the positive difference, if any, between the closing market value of our common stock on December 31, 2013 ($15.20) and the exercise price of the underlying options. | ||||||||||||
The weighted-average intrinsic value of stock options exercised during the three months ended December 31, 2013 and 2012 was $1.2 million and $5.2 million, respectively. | |||||||||||||
Restricted Units | |||||||||||||
Restricted Units are not included in issued and outstanding common stock until the shares are vested and released. The purchase price for vested Restricted Units is $0.001 per share. The table below summarizes activity relating to Restricted Units for the three months ended December 31, 2013: | |||||||||||||
Number of Shares Underlying Restricted Units — Contingent Awards | Number of Shares Underlying Restricted Units — Time-Based Awards | ||||||||||||
Outstanding at September 30, 2013 | 5,587,181 | 9,095,424 | |||||||||||
Granted | 1,404,938 | 3,605,109 | |||||||||||
Earned/released | (745,689 | ) | (3,242,497 | ) | |||||||||
Forfeited | (1,289,490 | ) | (195,182 | ) | |||||||||
Outstanding at December 31, 2013 | 4,956,940 | 9,262,854 | |||||||||||
Weighted average remaining recognition period of outstanding Restricted Units | 2.0 years | 1.9 years | |||||||||||
Unearned stock-based compensation expense of outstanding Restricted Units | $75.1 million | $131.2 million | |||||||||||
Aggregate intrinsic value of outstanding Restricted Units(a) | $75.3 million | $140.9 million | |||||||||||
(a) | The aggregate intrinsic value in this table was calculated based on the positive difference between the closing market value of our common stock on December 31, 2013 ($15.20) and the purchase price of the underlying Restricted Units. | ||||||||||||
A summary of weighted-average grant-date fair value for awards granted and intrinsic value of all Restricted Units vested during the periods noted is as follows: | |||||||||||||
Three Months Ended December 31, | |||||||||||||
2013 | 2012 | ||||||||||||
Weighted-average grant-date fair value per share | $ | 14.59 | $ | 22.25 | |||||||||
Total intrinsic value of shares vested (in millions) | $ | 59 | $ | 100.9 | |||||||||
Restricted Stock Awards | |||||||||||||
Restricted Stock Awards are included in the issued and outstanding common stock at the date of grant. The table below summarizes activity related to Restricted Stock Awards for the three months ended December 31, 2013: | |||||||||||||
Number of Shares Underlying Restricted Stock | Weighted Average Grant Date Fair Value | ||||||||||||
Outstanding at September 30, 2013 | 1,000,000 | $ | 24.06 | ||||||||||
Granted | 250,000 | $ | 15.71 | ||||||||||
Vested | (250,000 | ) | $ | 25.8 | |||||||||
Forfeited | — | $ | — | ||||||||||
Outstanding at December 31, 2013 | 1,000,000 | $ | 21.54 | ||||||||||
Weighted average remaining recognition period of outstanding Restricted Awards | 1.6 years | ||||||||||||
Unearned stock-based compensation expense of outstanding Restricted Awards | $19.7 million | ||||||||||||
Aggregate intrinsic value of outstanding Restricted Awards | $15.2 million | ||||||||||||
A summary of weighted-average grant-date fair value for awards granted and intrinsic value of all Restricted Stock Awards vested during the periods noted is as follows: | |||||||||||||
Three Months Ended December 31, | |||||||||||||
2013 | 2012 | ||||||||||||
Weighted-average grant-date fair value per share | $ | 15.71 | $ | 22.32 | |||||||||
Total intrinsic value of shares vested (in millions) | $ | 3.9 | $ | 5.3 | |||||||||
Income_Taxes
Income Taxes | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Income Tax Disclosure [Abstract] | ' | |||||||
Income Taxes | ' | |||||||
me Taxes | ||||||||
The components of provision (benefit) from income taxes are as follows (dollars in thousands): | ||||||||
Three Months Ended December 31, | ||||||||
2013 | 2012 | |||||||
Domestic | $ | (1,455 | ) | $ | (16,488 | ) | ||
Foreign | 4,433 | 7,927 | ||||||
Provision (benefit) from income taxes | $ | 2,978 | $ | (8,561 | ) | |||
Effective tax rate | (5.7 | )% | 27.9 | % | ||||
The effective income tax rate was (5.7)% and 27.9% for the three months ended December 31, 2013 and 2012, respectively. Our current effective tax rate differs from the U.S. federal statutory rate of 35% primarily due to earnings in foreign operations which are subject to a significantly lower tax rate than the U.S. statutory tax rate driven primarily by our subsidiaries in Ireland. The effective tax rate for the three months ended December 31, 2013 was also impacted by a $5.2 million benefit for income taxes due to the release of a portion of the domestic valuation allowance resulting from a one-time tax benefit recorded in connection with an immaterial acquisition for which a net deferred tax liability was established related to acquired intangible assets. | ||||||||
Our effective income tax rate is based upon the income for the year, the composition of income in different countries, changes relating to valuation allowances for certain countries if and as necessary, and adjustments, if any, for the potential tax consequences, benefits or resolutions of audits or other tax contingencies. Our aggregate income tax rate in foreign jurisdictions is lower than our income tax rate in the United States. Our effective tax rate may be adversely affected by earnings being lower than anticipated in countries where we have lower statutory tax rates and higher than anticipated in countries where we have higher statutory tax rates. For the three months ended December 31, 2013, our international profits are lower as compared to the three months ended December 31, 2012, and therefore, the impact on our effective tax rate from our foreign operations is lower in the first quarter of fiscal 2014 as compared to prior year. | ||||||||
At December 31, 2013 and September 30, 2013, the liability for income taxes associated with uncertain tax positions was $20.1 million and $19.6 million, respectively, and is included in other long-term liabilities. If these benefits were recognized, they would favorably impact the effective tax rate. We do not expect a significant change in the amount of unrecognized tax benefits within the next twelve months. |
Commitments_and_Contingencies
Commitments and Contingencies | 3 Months Ended |
Dec. 31, 2013 | |
Commitments and Contingencies Disclosure [Abstract] | ' |
Commitments and Contingencies | ' |
Commitments and Contingencies | |
Litigation and Other Claims | |
Like many companies in the software industry, we have, from time to time, been notified of claims that we may be infringing on, or contributing to the infringement of, the intellectual property rights of others. These claims have been referred to counsel, and they are in various stages of evaluation and negotiation. If it appears necessary or desirable, we may seek licenses for these intellectual property rights. There is no assurance that licenses will be offered by all claimants, that the terms of any offered licenses will be acceptable to us or that in all cases the dispute will be resolved without litigation, which may be time consuming and expensive, and may result in injunctive relief or the payment of damages by us. | |
We do not believe that the resolution of any such claim or litigation will have a material adverse effect on our financial position and results of operations. However, resolution of any such claim or litigation could require significant management time and adversely impact our operating results, financial position and cash flows. | |
Guarantees and Other | |
We include indemnification provisions in the contracts we enter into with customers and business partners. Generally, these provisions require us to defend claims arising out of our products’ infringement of third-party intellectual property rights, breach of contractual obligations and/or unlawful or otherwise culpable conduct. The indemnity obligations generally cover damages, costs and attorneys’ fees arising out of such claims. In most, but not all cases, our total liability under such provisions is limited to either the value of the contract or a specified, agreed upon amount. In some cases our total liability under such provisions is unlimited. In many, but not all cases, the term of the indemnity provision is perpetual. While the maximum potential amount of future payments we could be required to make under all the indemnification provisions is unlimited, we believe the estimated fair value of these provisions is minimal due to the low frequency with which these provisions have been triggered. | |
We indemnify our directors and officers to the fullest extent permitted by law. These agreements, among other things, indemnify directors and officers for expenses, judgments, fines, penalties and settlement amounts incurred by such persons in their capacity as a director or officer of the company, regardless of whether the individual is serving in any such capacity at the time the liability or expense is incurred. Additionally, in connection with certain acquisitions we have agreed to indemnify the former officers and members of the boards of directors of those companies, on similar terms as described above, for a period of six years from the acquisition date. In certain cases we purchase director and officer insurance policies related to these obligations, which fully cover the six year periods. To the extent that we do not purchase a director and officer insurance policy for the full period of any contractual indemnification, we would be required to pay for costs incurred, if any, as described above. |
Segment_and_Geographic_Informa
Segment and Geographic Information and Significant Customers | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Segment Reporting [Abstract] | ' | |||||||
Segment and Geographic Information and Significant Customers | ' | |||||||
Segment and Geographic Information and Significant Customers | ||||||||
We operate in, and report financial information for, the following four reportable segments: Healthcare, Mobile and Consumer, Enterprise and Imaging. Segment profit is an important measure used for evaluating performance and for decision-making purposes and reflects the direct controllable costs of each segment together with an allocation of sales and corporate marketing expenses, and certain research and development project costs that benefit multiple product offerings. Segment profit represents income from operations excluding stock-based compensation, amortization of intangible assets, acquisition-related costs (income), net, restructuring and other charges, net, costs associated with intellectual property collaboration agreements, other income (expense), net and certain unallocated corporate expenses. | ||||||||
We do not track our assets by operating segment; consequently, it is not practical to show assets or depreciation by operating segment. The following table presents segment results along with a reconciliation of segment profit to loss before income taxes (dollars in thousands): | ||||||||
Three months ended | ||||||||
December 31, | ||||||||
2013 | 2012 | |||||||
Segment revenues(a): | ||||||||
Healthcare | $ | 227,286 | $ | 217,374 | ||||
Mobile and Consumer | 115,262 | 131,731 | ||||||
Enterprise | 89,202 | 83,696 | ||||||
Imaging | 58,295 | 59,616 | ||||||
Total segment revenues | 490,045 | 492,417 | ||||||
Acquisition-related revenues | (20,065 | ) | (30,149 | ) | ||||
Total consolidated revenues | 469,980 | 462,268 | ||||||
Segment profit: | ||||||||
Healthcare | 78,460 | 89,135 | ||||||
Mobile and Consumer | 13,442 | 39,826 | ||||||
Enterprise | 21,134 | 21,669 | ||||||
Imaging | 22,680 | 23,060 | ||||||
Total segment profit | 135,716 | 173,690 | ||||||
Corporate expenses and other, net | (31,206 | ) | (30,137 | ) | ||||
Acquisition-related revenues and cost of revenues adjustment | (18,832 | ) | (27,666 | ) | ||||
Stock-based compensation | (47,239 | ) | (45,271 | ) | ||||
Amortization of intangible assets | (42,666 | ) | (41,736 | ) | ||||
Acquisition-related costs, net | (2,798 | ) | (15,733 | ) | ||||
Restructuring and other charges, net | (3,837 | ) | (1,667 | ) | ||||
Costs associated with IP collaboration agreements | (4,937 | ) | (5,250 | ) | ||||
Other expense, net | (36,636 | ) | (36,887 | ) | ||||
Loss before income taxes | $ | (52,435 | ) | $ | (30,657 | ) | ||
(a) | Segment revenues differ from reported revenues due to certain revenue adjustments related to acquisitions that would otherwise have been recognized but for the purchase accounting treatment of the business combinations. Segment revenues also include revenue that the business would have otherwise recognized had we not acquired intellectual property and other assets from the same customer. These revenues are included to allow for more complete comparisons to the financial results of historical operations and in evaluating management performance. | |||||||
No country outside of the United States provided greater than 10% of our total revenue. Revenue, classified by the major geographic areas in which our customers are located, was as follows (dollars in thousands): | ||||||||
Three months ended | ||||||||
December 31, | ||||||||
2013 | 2012 | |||||||
United States | $ | 343,185 | $ | 340,288 | ||||
International | 126,795 | 121,980 | ||||||
Total revenues | $ | 469,980 | $ | 462,268 | ||||
Summary_of_Significant_Account1
Summary of Significant Accounting Policies Recently Issued Accounting Pronouncements (Tables) | 3 Months Ended |
Dec. 31, 2013 | |
Recently Issued Accounting Pronouncements [Abstract] | ' |
New Accounting Pronouncements, Policy [Policy Text Block] | ' |
Recently Issued Accounting Standards | |
In July 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2013-11, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists" (ASU 2013-11) to provide guidance on the presentation of unrecognized tax benefits. ASU 2013-11 requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows: to the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. ASU 2013-11 is effective for us in our first quarter of fiscal 2015 with earlier adoption permitted. ASU 2013-11 should be applied prospectively with retroactive application permitted. We do not believe that this will have a material impact on our consolidated financial statements. |
Business_Acquisitions_Tables
Business Acquisitions (Tables) | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Business Combinations [Abstract] | ' | |||||||
Pro Forma Results of Operations | ' | |||||||
The following table shows unaudited pro forma results of operations as if we had acquired TGT on October 1, 2012 (dollars in thousands, except per share amounts): | ||||||||
Three Months Ended December 31, | ||||||||
2013 | 2012 | |||||||
Revenue | $ | 469,980 | $ | 464,364 | ||||
Net loss | (55,413 | ) | (25,669 | ) | ||||
Net loss per share - diluted | $ | (0.18 | ) | $ | (0.08 | ) | ||
Components of Acquisition-Related Costs, Net | ' | |||||||
The components of acquisition-related costs, net are as follows (dollars in thousands): | ||||||||
Three Months Ended December 31, | ||||||||
2013 | 2012 | |||||||
Transition and integration costs | $ | 3,839 | $ | 6,263 | ||||
Professional service fees | 3,339 | 9,470 | ||||||
Acquisition-related adjustments | (4,380 | ) | — | |||||
Total | $ | 2,798 | $ | 15,733 | ||||
Included in acquisition-related adjustments for the three months ended December 31, 2013, is income of $7.7 million related to the elimination of a contingent liability established in the original allocation of purchase price for an acquisition closed in fiscal 2008, following the expiration of the applicable statute of limitations. As a result, we have eliminated the contingent liability, and included the adjustment in acquisition-related costs, net in our consolidated statements of operations. |
Goodwill_and_Intangible_Assets1
Goodwill and Intangible Assets (Tables) | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | |||||||
Changes in Carrying Amount of Goodwill and Intangible Assets | ' | |||||||
The changes in the carrying amount of goodwill and intangible assets for the three months ended December 31, 2013, are as follows (dollars in thousands): | ||||||||
Goodwill | Intangible | |||||||
Assets | ||||||||
Balance at September 30, 2013 | $ | 3,293,198 | $ | 953,278 | ||||
Acquisitions | 51,871 | 43,409 | ||||||
Purchase accounting adjustments | 542 | (59 | ) | |||||
Amortization | — | (42,666 | ) | |||||
Effect of foreign currency translation | 4,760 | 347 | ||||||
Balance at December 31, 2013 | $ | 3,350,371 | $ | 954,309 | ||||
Financial_Instruments_and_Hedg1
Financial Instruments and Hedging Activities (Tables) | 3 Months Ended | ||||||||||
Dec. 31, 2013 | |||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ||||||||||
Summary of Outstanding Shares Subject to Security Price Guarantees | ' | ||||||||||
The following is a summary of the outstanding shares subject to security price guarantees at December 31, 2013 (dollars in thousands): | |||||||||||
Issue Date | Number of Shares Issued | Settlement Date | Total Value of Shares | ||||||||
on Issue Date | |||||||||||
August 15, 2013 | 934,960 | February 15, 2014 | $ | 18,400 | |||||||
Quantitative Summary of Fair Value of Derivative Instruments | ' | ||||||||||
The following table provides a quantitative summary of the fair value of our derivative instruments as of December 31, 2013 and September 30, 2013 (dollars in thousands): | |||||||||||
Derivatives Not Designated as Hedges: | Balance Sheet Classification | Fair Value | |||||||||
31-Dec-13 | 30-Sep-13 | ||||||||||
Foreign currency contracts | Prepaid expenses and other current assets | $ | 949 | $ | 2,201 | ||||||
Security Price Guarantees | Accrued expenses and other current liabilities | (4,182 | ) | (1,044 | ) | ||||||
Net fair value of non-hedge derivative instruments | $ | (3,233 | ) | $ | 1,157 | ||||||
Summarized Activity of Derivative Instruments | ' | ||||||||||
The following tables summarize the activity of derivative instruments for the three months ended December 31, 2013 and 2012 (dollars in thousands): | |||||||||||
Amount of Gain (Loss) Recognized in Income | |||||||||||
Derivatives Not Designated as Hedges | Location of Gain (Loss) Recognized in Income | 2013 | 2012 | ||||||||
Foreign currency contracts | Other expense, net | $ | 1,963 | $ | (104 | ) | |||||
Security price guarantees | Other expense, net | $ | (4,150 | ) | $ | (2,510 | ) |
Fair_Value_Measures_Tables
Fair Value Measures (Tables) | 3 Months Ended | |||||||||||||||
Dec. 31, 2013 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ' | |||||||||||||||
Assets and Liabilities Measured at Fair Value on Recurring Basis | ' | |||||||||||||||
Assets and liabilities measured at fair value on a recurring basis at December 31, 2013 and September 30, 2013 consisted of (dollars in thousands): | ||||||||||||||||
31-Dec-13 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: | ||||||||||||||||
Money market funds(a) | $ | 617,061 | $ | — | $ | — | $ | 617,061 | ||||||||
US government agency securities(a) | 1,000 | — | — | 1,000 | ||||||||||||
Marketable securities, $40,440 at cost (b) | — | 40,440 | — | 40,440 | ||||||||||||
Foreign currency exchange contracts(b) | — | 949 | — | 949 | ||||||||||||
Total assets at fair value | $ | 618,061 | $ | 41,389 | $ | — | $ | 659,450 | ||||||||
Liabilities: | ||||||||||||||||
Security price guarantees(c) | $ | — | $ | (4,182 | ) | $ | — | $ | (4,182 | ) | ||||||
Contingent earn-out(d) | — | — | (1,319 | ) | (1,319 | ) | ||||||||||
Total liabilities at fair value | $ | — | $ | (4,182 | ) | $ | (1,319 | ) | $ | (5,501 | ) | |||||
30-Sep-13 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: | ||||||||||||||||
Money market funds(a) | $ | 684,697 | $ | — | $ | — | $ | 684,697 | ||||||||
US government agency securities(a) | 1,000 | — | — | 1,000 | ||||||||||||
Marketable securities, $38,728 at cost (b) | — | 38,728 | — | 38,728 | ||||||||||||
Foreign currency exchange contracts(b) | — | 2,201 | — | 2,201 | ||||||||||||
Total assets at fair value | $ | 685,697 | $ | 40,929 | $ | — | $ | 726,626 | ||||||||
Liabilities: | ||||||||||||||||
Security price guarantees(c) | $ | — | $ | (1,044 | ) | $ | — | $ | (1,044 | ) | ||||||
Contingent earn-out(d) | — | — | (450 | ) | (450 | ) | ||||||||||
Total liabilities at fair value | $ | — | $ | (1,044 | ) | $ | (450 | ) | $ | (1,494 | ) | |||||
(a) | Money market funds and U.S. government agency securities, included in cash and cash equivalents in the accompanying balance sheets, are valued at quoted market prices in active markets. | |||||||||||||||
(b) | The fair values of our time deposits, marketable securities and foreign currency exchange contracts are based on the most recent observable inputs for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable. | |||||||||||||||
(c) | The fair values of the security price guarantees are determined using a modified Black-Scholes model, derived from observable inputs such as U.S. treasury interest rates, our common stock price, and the volatility of our common stock. The valuation model values both the put and call components of the guarantees simultaneously, with the net value of those components representing the fair value of each instrument. | |||||||||||||||
(d) | The fair value of our contingent consideration arrangements are determined based on our evaluation as to the probability and amount of any earn-out that will be achieved based on expected future performance by the acquired entity. | |||||||||||||||
Changes in Fair Value of Contingent Earn-Out Liabilities | ' | |||||||||||||||
The changes in the fair value of contingent earn-out liabilities are as follows (dollars in thousands): | ||||||||||||||||
Three Months Ended December 31, | ||||||||||||||||
2013 | ||||||||||||||||
Balance at beginning of period | $ | 450 | ||||||||||||||
Earn-out liability established at time of acquisition | 869 | |||||||||||||||
Balance at end of period | $ | 1,319 | ||||||||||||||
Accrued_Expenses_and_Other_Cur1
Accrued Expenses and Other Current Liabilities (Tables) | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Payables and Accruals [Abstract] | ' | |||||||
Accrued Expenses and Other Current Liabilities | ' | |||||||
Accrued expenses and other current liabilities consisted of the following (dollars in thousands): | ||||||||
31-Dec-13 | 30-Sep-13 | |||||||
Compensation | $ | 91,875 | $ | 112,756 | ||||
Acquisition costs and liabilities | 31,546 | 15,722 | ||||||
Accrued interest payable | 27,005 | 15,879 | ||||||
Cost of revenue related liabilities | 18,600 | 17,992 | ||||||
Professional fees | 15,881 | 17,682 | ||||||
Sales and marketing incentives | 12,803 | 11,681 | ||||||
Sales and other taxes payable | 11,980 | 10,625 | ||||||
Other | 17,492 | 12,088 | ||||||
Total | $ | 227,182 | $ | 214,425 | ||||
Deferred_Revenue_Tables
Deferred Revenue (Tables) | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Deferred Revenue [Abstract] | ' | |||||||
Deferred Revenue | ' | |||||||
Deferred revenue consisted of the following (dollars in thousands): | ||||||||
31-Dec-13 | 30-Sep-13 | |||||||
Current Liabilities: | ||||||||
Deferred maintenance revenue | $ | 136,552 | $ | 134,213 | ||||
Unearned revenue | 164,497 | 119,540 | ||||||
Total current deferred revenue | $ | 301,049 | $ | 253,753 | ||||
Long-term Liabilities: | ||||||||
Deferred maintenance revenue | $ | 58,312 | $ | 51,784 | ||||
Unearned revenue | 124,893 | 109,039 | ||||||
Total long-term deferred revenue | $ | 183,205 | $ | 160,823 | ||||
Restructuring_and_Other_Charge1
Restructuring and Other Charges, net (Tables) | 3 Months Ended | |||||||||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | ' | |||||||||||||||||||||||
Accrual Activity Relating to Restructuring and Other Charges | ' | |||||||||||||||||||||||
The following table sets forth accrual activity relating to our restructuring reserves for the three months ended December 31, 2013 (dollars in thousands): | ||||||||||||||||||||||||
Personnel | Facilities | Total | ||||||||||||||||||||||
Balance at September 30, 2013 | $ | 4,230 | $ | 1,191 | $ | 5,421 | ||||||||||||||||||
Restructuring charges, net | 1,419 | 2,418 | 3,837 | |||||||||||||||||||||
Non-cash adjustments | 80 | 761 | 841 | |||||||||||||||||||||
Cash payments | (3,261 | ) | (607 | ) | (3,868 | ) | ||||||||||||||||||
Balance at December 31, 2013 | $ | 2,468 | $ | 3,763 | $ | 6,231 | ||||||||||||||||||
Restructuring and Other Charges, Net by Segment | ' | |||||||||||||||||||||||
Restructuring charges, net by segment are as follows (dollars in thousands): | ||||||||||||||||||||||||
Three Months Ended December 31, | ||||||||||||||||||||||||
2013 | 2012 | |||||||||||||||||||||||
Personnel | Facilities | Total | Personnel | Facilities | Total | |||||||||||||||||||
Healthcare | $ | 214 | $ | — | $ | 214 | $ | 653 | $ | 558 | $ | 1,211 | ||||||||||||
Mobile and Consumer | 202 | — | 202 | 1,099 | — | 1,099 | ||||||||||||||||||
Enterprise | 177 | — | 177 | — | — | — | ||||||||||||||||||
Imaging | — | — | — | 822 | — | 822 | ||||||||||||||||||
Corporate | 826 | 2,418 | 3,244 | 143 | — | 143 | ||||||||||||||||||
Total restructuring expense | $ | 1,419 | $ | 2,418 | $ | 3,837 | $ | 2,717 | $ | 558 | $ | 3,275 | ||||||||||||
Debt_and_Credit_Facilities_Tab
Debt and Credit Facilities (Tables) | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Debt Disclosure [Abstract] | ' | |||||||
Borrowing Obligations and Applicable Margin for Borrowings | ' | |||||||
The applicable margin for the borrowings at December 31, 2013 is as follows: | ||||||||
Description | Base Rate Margin | LIBOR Margin | ||||||
Term loans maturing August 2019 | 1.75% | 2.75% | ||||||
Revolving facility due August 2018 | 0.50% - 0.75% (a) | 1.50% - 1.75% (a) | ||||||
(a) | The margin is determined based on our net leverage ratio at the date the interest rates are reset on the revolving credit line. | |||||||
At December 31, 2013 and September 30, 2013, we had the following borrowing obligations (dollars in thousands): | ||||||||
31-Dec-13 | 30-Sep-13 | |||||||
5.375% Senior Notes due 2020, net of unamortized premium of $5.2 million and $5.4 million, respectively. Effective interest rate 5.28%. | $ | 1,055,190 | $ | 1,055,385 | ||||
2.75% Convertible Debentures due 2031, net of unamortized discount of $107.5 million and $113.5 million, respectively. Effective interest rate 7.43%. | 582,529 | 576,524 | ||||||
2.75% Convertible Debentures due 2027, net of unamortized discount of $6.3 million and $8.8 million, respectively. Effective interest rate 7.30%. | 243,683 | 241,206 | ||||||
Credit Facility, net of unamortized discount of $1.1 million and $1.2 million, respectively. | 479,875 | 481,016 | ||||||
Total long-term debt | $ | 2,361,277 | $ | 2,354,131 | ||||
Less: current portion | 248,518 | 246,040 | ||||||
Non-current portion of long-term debt | $ | 2,112,759 | $ | 2,108,091 | ||||
StockBased_Compensation_Tables
Stock-Based Compensation (Tables) | 3 Months Ended | ||||||||||||
Dec. 31, 2013 | |||||||||||||
Share-based Compensation [Abstract] | ' | ||||||||||||
Stock Based Compensation Included in Consolidated Statements of Operations | ' | ||||||||||||
The amounts included in the consolidated statements of operations relating to stock-based compensation are as follows (dollars in thousands): | |||||||||||||
Three Months Ended December 31, | |||||||||||||
2013 | 2012 | ||||||||||||
Cost of product and licensing | $ | 265 | $ | 185 | |||||||||
Cost of professional services and hosting | 6,619 | 2,403 | |||||||||||
Cost of maintenance and support | 784 | 2,103 | |||||||||||
Research and development | 10,288 | 8,860 | |||||||||||
Selling and marketing | 15,244 | 16,847 | |||||||||||
General and administrative | 14,039 | 14,873 | |||||||||||
Total | $ | 47,239 | $ | 45,271 | |||||||||
Summary of Stock Options Activity | ' | ||||||||||||
The table below summarizes activity relating to stock options for the three months ended December 31, 2013: | |||||||||||||
Number of | Weighted | Weighted | Aggregate | ||||||||||
Shares | Average | Average | Intrinsic | ||||||||||
Exercise | Remaining | Value(a) | |||||||||||
Price | Contractual | ||||||||||||
Term | |||||||||||||
Outstanding at September 30, 2013 | 4,184,158 | $ | 13.08 | ||||||||||
Exercised | (140,260 | ) | $ | 8.47 | |||||||||
Forfeited | (974 | ) | $ | 20.04 | |||||||||
Expired | (2,393 | ) | $ | 17.46 | |||||||||
Outstanding at December 31, 2013 | 4,040,531 | $ | 13.23 | 2.7 years | $ | 9.8 | million | ||||||
Exercisable at December 31, 2013 | 4,019,980 | $ | 13.23 | 2.7 years | $ | 9.7 | million | ||||||
Exercisable at December 31, 2012 | 5,715,146 | $ | 11.54 | 2.9 years | $ | 61.6 | million | ||||||
(a) | The aggregate intrinsic value in this table was calculated based on the positive difference, if any, between the closing market value of our common stock on December 31, 2013 ($15.20) and the exercise price of the underlying options. | ||||||||||||
Summary of Activity Relating to Restricted Units and Restricted Stock Awards | ' | ||||||||||||
Restricted Stock Awards are included in the issued and outstanding common stock at the date of grant. The table below summarizes activity related to Restricted Stock Awards for the three months ended December 31, 2013: | |||||||||||||
Number of Shares Underlying Restricted Stock | Weighted Average Grant Date Fair Value | ||||||||||||
Outstanding at September 30, 2013 | 1,000,000 | $ | 24.06 | ||||||||||
Granted | 250,000 | $ | 15.71 | ||||||||||
Vested | (250,000 | ) | $ | 25.8 | |||||||||
Forfeited | — | $ | — | ||||||||||
Outstanding at December 31, 2013 | 1,000,000 | $ | 21.54 | ||||||||||
Weighted average remaining recognition period of outstanding Restricted Awards | 1.6 years | ||||||||||||
Unearned stock-based compensation expense of outstanding Restricted Awards | $19.7 million | ||||||||||||
Aggregate intrinsic value of outstanding Restricted Awards | $15.2 million | ||||||||||||
The table below summarizes activity relating to Restricted Units for the three months ended December 31, 2013: | |||||||||||||
Number of Shares Underlying Restricted Units — Contingent Awards | Number of Shares Underlying Restricted Units — Time-Based Awards | ||||||||||||
Outstanding at September 30, 2013 | 5,587,181 | 9,095,424 | |||||||||||
Granted | 1,404,938 | 3,605,109 | |||||||||||
Earned/released | (745,689 | ) | (3,242,497 | ) | |||||||||
Forfeited | (1,289,490 | ) | (195,182 | ) | |||||||||
Outstanding at December 31, 2013 | 4,956,940 | 9,262,854 | |||||||||||
Weighted average remaining recognition period of outstanding Restricted Units | 2.0 years | 1.9 years | |||||||||||
Unearned stock-based compensation expense of outstanding Restricted Units | $75.1 million | $131.2 million | |||||||||||
Aggregate intrinsic value of outstanding Restricted Units(a) | $75.3 million | $140.9 million | |||||||||||
(a) | The aggregate intrinsic value in this table was calculated based on the positive difference between the closing market value of our common stock on December 31, 2013 ($15.20) and the purchase price of the underlying Restricted Units. | ||||||||||||
Summary of Weighted-Average Grant-Date Fair Value and Intrinsic Value of Restricted Units and Restricted Stock Awards Vested | ' | ||||||||||||
A summary of weighted-average grant-date fair value for awards granted and intrinsic value of all Restricted Stock Awards vested during the periods noted is as follows: | |||||||||||||
Three Months Ended December 31, | |||||||||||||
2013 | 2012 | ||||||||||||
Weighted-average grant-date fair value per share | $ | 15.71 | $ | 22.32 | |||||||||
Total intrinsic value of shares vested (in millions) | $ | 3.9 | $ | 5.3 | |||||||||
A summary of weighted-average grant-date fair value for awards granted and intrinsic value of all Restricted Units vested during the periods noted is as follows: | |||||||||||||
Three Months Ended December 31, | |||||||||||||
2013 | 2012 | ||||||||||||
Weighted-average grant-date fair value per share | $ | 14.59 | $ | 22.25 | |||||||||
Total intrinsic value of shares vested (in millions) | $ | 59 | $ | 100.9 | |||||||||
Income_Taxes_Tables
Income Taxes (Tables) | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Income Tax Disclosure [Abstract] | ' | |||||||
Components of Benefit from Income Taxes | ' | |||||||
components of provision (benefit) from income taxes are as follows (dollars in thousands): | ||||||||
Three Months Ended December 31, | ||||||||
2013 | 2012 | |||||||
Domestic | $ | (1,455 | ) | $ | (16,488 | ) | ||
Foreign | 4,433 | 7,927 | ||||||
Provision (benefit) from income taxes | $ | 2,978 | $ | (8,561 | ) | |||
Effective tax rate | (5.7 | )% | 27.9 | % | ||||
The |
Segment_and_Geographic_Informa1
Segment and Geographic Information and Significant Customers (Tables) | 3 Months Ended | |||||||
Dec. 31, 2013 | ||||||||
Segment Reporting [Abstract] | ' | |||||||
Segment Results Along with Reconciliation of Segment Profit to Income Before Income Taxes | ' | |||||||
The following table presents segment results along with a reconciliation of segment profit to loss before income taxes (dollars in thousands): | ||||||||
Three months ended | ||||||||
December 31, | ||||||||
2013 | 2012 | |||||||
Segment revenues(a): | ||||||||
Healthcare | $ | 227,286 | $ | 217,374 | ||||
Mobile and Consumer | 115,262 | 131,731 | ||||||
Enterprise | 89,202 | 83,696 | ||||||
Imaging | 58,295 | 59,616 | ||||||
Total segment revenues | 490,045 | 492,417 | ||||||
Acquisition-related revenues | (20,065 | ) | (30,149 | ) | ||||
Total consolidated revenues | 469,980 | 462,268 | ||||||
Segment profit: | ||||||||
Healthcare | 78,460 | 89,135 | ||||||
Mobile and Consumer | 13,442 | 39,826 | ||||||
Enterprise | 21,134 | 21,669 | ||||||
Imaging | 22,680 | 23,060 | ||||||
Total segment profit | 135,716 | 173,690 | ||||||
Corporate expenses and other, net | (31,206 | ) | (30,137 | ) | ||||
Acquisition-related revenues and cost of revenues adjustment | (18,832 | ) | (27,666 | ) | ||||
Stock-based compensation | (47,239 | ) | (45,271 | ) | ||||
Amortization of intangible assets | (42,666 | ) | (41,736 | ) | ||||
Acquisition-related costs, net | (2,798 | ) | (15,733 | ) | ||||
Restructuring and other charges, net | (3,837 | ) | (1,667 | ) | ||||
Costs associated with IP collaboration agreements | (4,937 | ) | (5,250 | ) | ||||
Other expense, net | (36,636 | ) | (36,887 | ) | ||||
Loss before income taxes | $ | (52,435 | ) | $ | (30,657 | ) | ||
(a) | Segment revenues differ from reported revenues due to certain revenue adjustments related to acquisitions that would otherwise have been recognized but for the purchase accounting treatment of the business combinations. Segment revenues also include revenue that the business would have otherwise recognized had we not acquired intellectual property and other assets from the same customer. These revenues are included to allow for more complete comparisons to the financial results of historical operations and in evaluating management performance. | |||||||
Classification of Revenue By Major Geographic Areas | ' | |||||||
Revenue, classified by the major geographic areas in which our customers are located, was as follows (dollars in thousands): | ||||||||
Three months ended | ||||||||
December 31, | ||||||||
2013 | 2012 | |||||||
United States | $ | 343,185 | $ | 340,288 | ||||
International | 126,795 | 121,980 | ||||||
Total revenues | $ | 469,980 | $ | 462,268 | ||||
Business_Acquisitions_Summary_
Business Acquisitions (Summary of Preliminary Allocation of Purchase Consideration) (Detail) (USD $) | Oct. 31, 2012 | 31-May-13 |
In Millions, unless otherwise specified | J.A. Thomas and Associates [Member] | TGT [Member] |
Business Acquisition [Line Items] | ' | ' |
Business Acquisition, Cost of Acquired Entity, Purchase Price, Total | ' | $83.30 |
Contingent consideration payments | $25 | ' |
Business_Acquisitions_Summary_1
Business Acquisitions (Summary of Preliminary Allocation of Purchase Consideration) (Parenthetical) (Detail) (USD $) | 3 Months Ended | |
Dec. 31, 2013 | 31-May-13 | |
TGT [Member] | ||
Business Acquisition [Line Items] | ' | ' |
Business Acquisition, Cost of Acquired Entity, Purchase Price, Total | ' | $83,300,000 |
Purchase accounting adjustment | $542,000 | ' |
Business_Acquisitions_Addition
Business Acquisitions (Additional Information) (Detail) (Other Acquisitions [Member], USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Dec. 31, 2013 |
Other Acquisitions [Member] | ' |
Business Acquisition [Line Items] | ' |
Business acquisition, purchase price | $101 |
Goodwill | 51.9 |
Identifiable intangible assets | $42.50 |
Weighted average life | '10 years |
Business_Acquisitions_Pro_Form
Business Acquisitions (Pro Forma Results of Operations) (Detail) (TGT [Member], USD $) | 3 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | 31-May-13 | |
TGT [Member] | ' | ' | ' |
Business Acquisition [Line Items] | ' | ' | ' |
Business Acquisition, Cost of Acquired Entity, Purchase Price, Total | ' | ' | $83,300,000 |
Revenue | 469,980,000 | 464,364,000 | ' |
Net income (loss) | ($55,413,000) | ($25,669,000) | ' |
Net income (loss) per share (in dollars per share) | ($0.18) | ($0.08) | ' |
Business_Acquisitions_Componen
Business Acquisitions (Components of Acquisition-Related Costs, Net) (Detail) (USD $) | 3 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Business Combinations [Abstract] | ' | ' |
Increase (Decrease) in Other Noncurrent Liabilities | ($7,700,000) | ' |
Transition and integration costs | 3,839,000 | 6,263,000 |
Professional service fees | 3,339,000 | 9,470,000 |
Business Combination Acquisition Related Adjustments | -4,380,000 | 0 |
Total | $2,798,000 | $15,733,000 |
Contingent_Acquisition_Payment1
Contingent Acquisition Payments (Detail) (J.A. Thomas and Associates [Member], USD $) | Oct. 31, 2012 |
In Millions, unless otherwise specified | |
J.A. Thomas and Associates [Member] | ' |
Business Acquisition, Contingent Consideration [Line Items] | ' |
Business Acquisition Contingent Consideration Potential CashPaymen | $25 |
Changes_in_Carrying_Amount_of_
Changes in Carrying Amount of Goodwill and Intangible Assets (Detail) (USD $) | 3 Months Ended |
In Thousands, unless otherwise specified | Dec. 31, 2013 |
Goodwill [Roll Forward] | ' |
Balance at September 30, 2013 | $3,293,198 |
Acquisitions | 51,871 |
Purchase accounting adjustments | 542 |
Amortization | 0 |
Effect of foreign currency translation | 4,760 |
Balance at December 31, 2013 | 3,350,371 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ' |
Balance at September 30, 2013 | 953,278 |
Acquisitions | 43,409 |
Purchase accounting adjustments | -59 |
Amortization | -42,666 |
Effect of foreign currency translation | 347 |
Balance at December 31, 2013 | $954,309 |
Financial_Instruments_and_Hedg2
Financial Instruments and Hedging Activities (Additional Information) (Detail) (USD $) | Dec. 31, 2013 | Sep. 30, 2013 | Dec. 31, 2013 | Sep. 30, 2013 | Dec. 31, 2013 |
In Millions, unless otherwise specified | Derivatives Not Designated as Hedges | Derivatives Not Designated as Hedges | Derivatives Not Designated as Hedges | ||
Maximum | |||||
Derivative Instruments and Hedging Activities Disclosure [Line Items] | ' | ' | ' | ' | ' |
Term of foreign currency forward contracts | ' | ' | ' | ' | '90 days |
Derivative, Notional Amount | ' | ' | $330.80 | $247.80 | ' |
Estimated fair value of long-term debt | 2,431.50 | 2,458.20 | ' | ' | ' |
Long-term debt, face value | $2,471 | $2,472.20 | ' | ' | ' |
Financial_Instruments_and_Hedg3
Financial Instruments and Hedging Activities (Summary of Outstanding Shares Subject to Security Price Guarantees) (Detail) (Security Price Guarantees Issued Date On August Fourteen Twenty Twelve [Member], USD $) | 3 Months Ended |
In Thousands, except Share data, unless otherwise specified | Dec. 31, 2013 |
Security Price Guarantees Issued Date On August Fourteen Twenty Twelve [Member] | ' |
Derivative [Line Items] | ' |
Issue Date | 15-Aug-13 |
Number of Shares Issued | 934,960 |
Settlement Date | 15-Feb-14 |
Total Value of Shares on Issue Date | $18,400 |
Financial_Instruments_and_Hedg4
Financial Instruments and Hedging Activities (Quantitative Summary of Fair Value of Derivative Instruments) (Detail) (USD $) | Dec. 31, 2013 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Derivatives, Fair Value [Line Items] | ' | ' |
Net asset (liability) value of non-hedged derivative instruments | ($3,233) | $1,157 |
Foreign currency contracts | Prepaid expenses and other current assets | ' | ' |
Derivatives, Fair Value [Line Items] | ' | ' |
Asset value of non-hedge derivative instruments | 949 | 2,201 |
Security Price Guarantees | Accrued Expenses And Other Current Liabilities [Member] | ' | ' |
Derivatives, Fair Value [Line Items] | ' | ' |
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value | $4,182 | $1,044 |
Financial_Instruments_and_Hedg5
Financial Instruments and Hedging Activities (Summarized Activity of Derivative Instruments) (Detail) (Derivatives Not Designated as Hedges, Other expense, net, USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Foreign currency contracts | ' | ' |
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' |
Amount of Gain (Loss) Recognized in Income | $1,963 | ($104) |
Security price guarantees | ' | ' |
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' |
Amount of Gain (Loss) Recognized in Income | ($4,150) | ($2,510) |
Fair_Value_Measures_Assets_and
Fair Value Measures (Assets and Liabilities Measured at Fair Value on Recurring Basis) (Detail) (USD $) | 3 Months Ended | |||
Dec. 31, 2013 | Sep. 30, 2013 | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | ||
Available-for-sale Securities, Amortized Cost Basis | $40,439,538 | $38,728,000 | ||
Document Period End Date | 31-Dec-13 | ' | ||
Fair Value, Measurements, Recurring | ' | ' | ||
Assets: | ' | ' | ||
Money market funds | 617,061,000 | [1] | 684,697,000 | [1] |
US government agency securities | 1,000,000 | [1] | 1,000,000 | [1] |
Available-for-sale Securities | 40,440,000 | 38,728,000 | ||
Foreign currency exchange contracts | 949,000 | [2] | 2,201,000 | [2] |
Security price guarantees | -4,182,000 | -1,044,000 | ||
Total assets at fair value | 659,450,000 | 726,626,000 | ||
Liabilities: | ' | ' | ||
Contingent earn-out | -1,319,000 | [3] | -450,000 | [3] |
Total liabilities at fair value | -5,501,000 | [4] | -1,494,000 | |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | ' | ' | ||
Assets: | ' | ' | ||
Money market funds | 617,061,000 | 684,697,000 | ||
US government agency securities | 1,000,000 | 1,000,000 | ||
Available-for-sale Securities | 0 | 0 | ||
Foreign currency exchange contracts | 0 | 0 | ||
Security price guarantees | 0 | 0 | ||
Total assets at fair value | 618,061,000 | 685,697,000 | ||
Liabilities: | ' | ' | ||
Contingent earn-out | 0 | 0 | ||
Total liabilities at fair value | 0 | [4] | 0 | |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | ' | ' | ||
Assets: | ' | ' | ||
Money market funds | 0 | 0 | ||
US government agency securities | 0 | 0 | ||
Available-for-sale Securities | 40,440,000 | 38,728,000 | ||
Foreign currency exchange contracts | 949,000 | 2,201,000 | ||
Security price guarantees | -4,182,000 | -1,044,000 | ||
Total assets at fair value | 41,389,000 | 40,929,000 | ||
Liabilities: | ' | ' | ||
Contingent earn-out | 0 | 0 | ||
Total liabilities at fair value | -4,182,000 | [4] | -1,044,000 | |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | ' | ' | ||
Assets: | ' | ' | ||
Money market funds | 0 | 0 | ||
US government agency securities | 0 | 0 | ||
Available-for-sale Securities | 0 | 0 | ||
Foreign currency exchange contracts | 0 | 0 | ||
Security price guarantees | 0 | 0 | ||
Total assets at fair value | 0 | 0 | ||
Liabilities: | ' | ' | ||
Contingent earn-out | -1,319,000 | -450,000 | ||
Total liabilities at fair value | ($1,319,000) | [4] | ($450,000) | |
[1] | Money market funds and U.S. government agency securities, included in cash and cash equivalents in the accompanying balance sheets, are valued at quoted market prices in active markets. | |||
[2] | The fair values of our time deposits, marketable securities and foreign currency exchange contracts are based on the most recent observable inputs for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable. | |||
[3] | The fair value of our contingent consideration arrangements are determined based on our evaluation as to the probability and amount of any earn-out that will be achieved based on expected future performance by the acquired entity. | |||
[4] | The fair values of the security price guarantees are determined using a modified Black-Scholes model, derived from observable inputs such as U.S. treasury interest rates, our common stock price, and the volatility of our common stock. The valuation model values both the put and call components of the guarantees simultaneously, with the net value of those components representing the fair value of each instrument. |
Fair_Value_Measures_Changes_in
Fair Value Measures (Changes in Fair Value of Contingent Earn-Out Liabilities) (Detail) (USD $) | 3 Months Ended |
In Thousands, unless otherwise specified | Dec. 31, 2013 |
Fair Value Disclosures [Abstract] | ' |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases | $869 |
Document Period End Date | 31-Dec-13 |
Balance at beginning of period | 450 |
Balance at end of period | $1,319 |
Accrued_Expenses_and_Other_Cur2
Accrued Expenses and Other Current Liabilities (Detail) (USD $) | Dec. 31, 2013 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Payables and Accruals [Abstract] | ' | ' |
Compensation | $91,875 | $112,756 |
Acquisition costs and liabilities | 31,546 | 15,722 |
Accrued interest payable | 27,005 | 15,879 |
Cost of revenue related liabilities | 18,600 | 17,992 |
Professional fees | 15,881 | 17,682 |
Sales and marketing incentives | 12,803 | 11,681 |
Sales and other taxes payable | 11,980 | 10,625 |
Other | 17,492 | 12,088 |
Total | $227,182 | $214,425 |
Deferred_Revenue_Detail
Deferred Revenue (Detail) (USD $) | Dec. 31, 2013 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||
Current deferred revenue | $301,049 | $253,753 |
Long-term deferred revenue | 183,205 | 160,823 |
Deferred maintenance revenue | ' | ' |
Current deferred revenue | 136,552 | 134,213 |
Long-term deferred revenue | 58,312 | 51,784 |
Unearned revenue | ' | ' |
Current deferred revenue | 164,497 | 119,540 |
Long-term deferred revenue | $124,893 | $109,039 |
Restructuring_and_Other_Charge2
Restructuring and Other Charges, net (Accrual Activity Relating to Restructuring and Other Charges) (Detail) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Restructuring [Roll Forward] | ' | ' |
Balance at September 30, 2013 | $5,421 | ' |
Restructuring and other charges, net | 3,837 | 3,275 |
Restructuring Reserve, Accrual Adjustment | 841 | ' |
Cash payments | 3,868 | ' |
Balance at December 31, 2013 | 6,231 | ' |
Personnel | ' | ' |
Restructuring [Roll Forward] | ' | ' |
Balance at September 30, 2013 | 4,230 | ' |
Restructuring and other charges, net | 1,419 | 2,717 |
Restructuring Reserve, Accrual Adjustment | 80 | ' |
Cash payments | 3,261 | ' |
Balance at December 31, 2013 | 2,468 | ' |
Facilities | ' | ' |
Restructuring [Roll Forward] | ' | ' |
Balance at September 30, 2013 | 1,191 | ' |
Restructuring and other charges, net | 2,418 | 558 |
Restructuring Reserve, Accrual Adjustment | 761 | ' |
Cash payments | 607 | ' |
Balance at December 31, 2013 | $3,763 | ' |
Restructuring_and_Other_Charge3
Restructuring and Other Charges, net (By Segment) (Detail) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | $3,837 | $3,275 |
Healthcare | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 214 | 1,211 |
Mobile and Consumer | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 202 | 1,099 |
Enterprise | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 177 | 0 |
Imaging | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 0 | 822 |
Corporate | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 3,244 | 143 |
Personnel | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 1,419 | 2,717 |
Personnel | Healthcare | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 214 | 653 |
Personnel | Mobile and Consumer | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 202 | 1,099 |
Personnel | Enterprise | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 177 | 0 |
Personnel | Imaging | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 0 | 822 |
Personnel | Corporate | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 826 | 143 |
Facilities | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 2,418 | 558 |
Facilities | Healthcare | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 0 | 558 |
Facilities | Mobile and Consumer | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 0 | 0 |
Facilities | Enterprise | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 0 | 0 |
Facilities | Imaging | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | 0 | 0 |
Facilities | Corporate | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and other charges, net | $2,418 | $0 |
Restructuring_and_Other_Charge4
Restructuring and Other Charges, net (Additional Information) (Detail) (USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Dec. 31, 2013 |
Person | |
Restructuring Cost and Reserve [Line Items] | ' |
Restructuring and other charges | $3.80 |
Number of personnel eliminated | 20 |
Personnel | ' |
Restructuring Cost and Reserve [Line Items] | ' |
Restructuring and other charges | 1.4 |
Facilities | ' |
Restructuring Cost and Reserve [Line Items] | ' |
Restructuring and other charges | $2.40 |
Debt_and_Credit_Facilities_Add
Debt and Credit Facilities (Additional Information) (Detail) (USD $) | 3 Months Ended | |
Dec. 31, 2013 | Sep. 30, 2013 | |
Debt Instrument [Line Items] | ' | ' |
Convertible debenture, face value | $2,471,000,000 | $2,472,200,000 |
Credit facility, outstanding | 479,875,000 | 481,016,000 |
Amended Credit Agreement | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Percentage of Capital Stock of Domestic Subsidiaries Pledged as Collateral | 100.00% | ' |
Revolving Credit Facility [Member] | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Debt instrument, unamortized discount | -1,100,000 | -1,200,000 |
Line of Credit Facility, Maximum Borrowing Capacity | 75,000,000 | ' |
Letters of credit, outstanding | 7,200,000 | ' |
Credit facility, commitment fee percentage for unused capacity | 0.38% | ' |
Revolving Credit Facility [Member] | Minimum | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Credit facility, commitment fee percentage for unused capacity | 0.38% | ' |
Revolving Credit Facility [Member] | Maximum | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Credit facility, commitment fee percentage for unused capacity | 0.50% | ' |
Term Loan | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Debt Covenants, Percentage of Net Cash Proceeds from Asset Sales | 100.00% | ' |
Debt Covenants, Percentage of Net Cash Proceeds from Issuance or Incurrence of Debt | 100.00% | ' |
Debt Covenants, Percentage of Extraordinary Receipts | 100.00% | ' |
Convertible Debentures Two Point Seven Five Percent Due November One Twenty Thirty One [Member] | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Debt instrument, stated interest rate | 2.75% | 2.75% |
Debt instrument, unamortized discount | 107,500,000 | 113,500,000 |
Debt Instrument, Interest Rate, Effective Percentage | 7.43% | 7.43% |
Debt Instrument Maturity Year | '2031 | ' |
2.75% Convertible Debentures due August 15, 2027 | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Debt instrument, stated interest rate | 2.75% | 2.75% |
Debt instrument, unamortized discount | 6,300,000 | 8,800,000 |
Debt Instrument, Interest Rate, Effective Percentage | 7.30% | 7.30% |
Debt Instrument Maturity Year | '2027 | ' |
5.375% Senior Notes due August 15, 2020 | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Senior notes, principal amount | 1,055,190,000 | 1,055,385,000 |
Debt instrument, stated interest rate | 5.38% | 5.38% |
Debt Instrument, Interest Rate, Effective Percentage | 5.28% | 5.28% |
Debt Instrument Maturity Year | '2020 | ' |
Unamortized Premium | ($5,200,000) | ($5,400,000) |
Term loans maturing March 2013 | LIBOR Margin | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Debt Instrument, Interest Rate, Effective Percentage | 2.92% | ' |
Voting Equity Interests [Member] | Amended Credit Agreement | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Percentage of Capital Stock of Foreign Subsidiaries Pledged as Collateral | 65.00% | ' |
Non-voting Equity Interests [Member] | Amended Credit Agreement | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Percentage of Capital Stock of Foreign Subsidiaries Pledged as Collateral | 100.00% | ' |
Debt_and_Credit_Facilities_Bor
Debt and Credit Facilities (Borrowing Obligations) (Detail) (USD $) | Dec. 31, 2013 | Sep. 30, 2013 |
Debt Instrument [Line Items] | ' | ' |
Credit Facility, net of unamortized discount of $1.1 million and $1.2 million, respectively. | $479,875,000 | $481,016,000 |
Total long-term debt | 2,361,277,000 | 2,354,131,000 |
Less: current portion | 248,518,000 | 246,040,000 |
Non-current portion of long-term debt | 2,112,759,000 | 2,108,091,000 |
5.375% Senior Notes due August 15, 2020 | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Debt instrument, stated interest rate | 5.38% | 5.38% |
Debt Instrument, Interest Rate, Effective Percentage | 5.28% | 5.28% |
Debt Instrument Maturity Year | '2020 | ' |
Unamortized Premium | -5,200,000 | -5,400,000 |
Senior Notes, net of unamortized premium | 1,055,190,000 | 1,055,385,000 |
Convertible Debentures Two Point Seven Five Percent Due November One Twenty Thirty One [Member] | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Debt instrument, stated interest rate | 2.75% | 2.75% |
Debt Instrument, Interest Rate, Effective Percentage | 7.43% | 7.43% |
Debt Instrument Maturity Year | '2031 | ' |
Debt instrument, unamortized discount | 107,500,000 | 113,500,000 |
Convertible Debentures, net of unamortized discount | 582,529,000 | 576,524,000 |
2.75% Convertible Debentures due August 15, 2027 | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Debt instrument, stated interest rate | 2.75% | 2.75% |
Debt Instrument, Interest Rate, Effective Percentage | 7.30% | 7.30% |
Debt Instrument Maturity Year | '2027 | ' |
Debt instrument, unamortized discount | 6,300,000 | 8,800,000 |
Convertible Debentures, net of unamortized discount | 243,683,000 | 241,206,000 |
Revolving Credit Facility [Member] | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Debt instrument, unamortized discount | ($1,100,000) | ($1,200,000) |
Debt_and_Credit_Facilities_App
Debt and Credit Facilities (Applicable Margin for Borrowings) (Detail) (USD $) | Dec. 31, 2013 | Sep. 30, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | ||||
Term Loan Facility Due August Seventh Twenty Ninteen [Member] | Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Base Rate Margin | Base Rate Margin | Base Rate Margin | LIBOR Margin | LIBOR Margin | LIBOR Margin | LIBOR Margin | Debt Instrument Amended And Restated [Member] | |||||||
Minimum | Maximum | Term Loan Facility Due August Seventh Twenty Ninteen [Member] | Revolving facility due March 2015 | Revolving facility due March 2015 | Term Loan Facility Due August Seventh Twenty Ninteen [Member] | Term loans maturing March 2013 | Revolving facility due March 2015 | Revolving facility due March 2015 | Term loans maturing March 2016 | |||||||||
Minimum | Maximum | Minimum | Maximum | |||||||||||||||
Line of Credit Facility [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Line of Credit Facility, Maximum Borrowing Capacity | ' | ' | ' | $75,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Applicable margin rate | ' | ' | 2.75% | ' | ' | ' | 1.75% | 0.50% | [1] | 0.75% | [1] | 2.75% | ' | 1.50% | [1] | 1.75% | [1] | ' |
Letters of credit, outstanding | ' | ' | ' | 7,200,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||
Debt Instrument, Interest Rate, Effective Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2.92% | ' | ' | ' | ||||
Credit Facility, net of unamortized discount of $1.1 million and $1.2 million, respectively. | $479,875,000 | $481,016,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $481,000,000 | ||||
Credit facility, commitment fee percentage for unused capacity | ' | ' | ' | 0.38% | 0.38% | 0.50% | ' | ' | ' | ' | ' | ' | ' | ' | ||||
[1] | The margin is determined based on our net leverage ratio at the date the interest rates are reset on the revolving credit line. |
Stockholders_Equity_Details
Stockholders' Equity (Details) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2013 | Apr. 29, 2013 |
Stockholders Equity Note [Line Items] | ' | ' |
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased | ' | $500 |
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased | 295.9 | ' |
Stock Repurchased During Period, Shares | 1.2 | ' |
Stock Repurchased During Period, Value | 19.7 | ' |
SharesRepurchasedNot YetSettled | 0.1 | ' |
Shares Repurchased Not Yet Settled, Value | $1.70 | ' |
Net_Loss_Income_Per_Share_Addi
Net (Loss) Income Per Share (Additional Information) (Detail) | 3 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Earnings Per Share, Basic and Diluted [Abstract] | ' | ' |
Anti-dilutive common equivalent shares excluded from computation of diluted net income (loss) per share | 13.7 | 14.8 |
StockBased_Compensation_Includ
Stock-Based Compensation (Included in Consolidated Statements of Operations) (Detail) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' |
Stock based compensation | $47,239 | $45,271 |
Cost of product and licensing | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' |
Stock based compensation | 265 | 185 |
Cost of professional services and hosting | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' |
Stock based compensation | 6,619 | 2,403 |
Cost of maintenance and support | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' |
Stock based compensation | 784 | 2,103 |
Research and development | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' |
Stock based compensation | 10,288 | 8,860 |
Selling and marketing | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' |
Stock based compensation | 15,244 | 16,847 |
General and administrative | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' |
Stock based compensation | $14,039 | $14,873 |
StockBased_Compensation_Additi
Stock-Based Compensation (Additional Information) (Detail) (USD $) | 3 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value | $1.20 | $5.20 |
Restricted Stock Awards | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Unearned stock-based compensation expense of outstanding Restricted Units | $19.70 | ' |
Weighted average remaining recognition period of outstanding Restricted Units | '1 year 7 months | ' |
Purchase price for restricted units, vested | $0.00 | ' |
StockBased_Compensation_Summar
Stock-Based Compensation (Summary of Stock Options Activity) (Detail) (USD $) | 3 Months Ended | |
In Millions, except Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Number of Shares | ' | ' |
Outstanding at September 30, 2013 | 4,184,158 | ' |
Exercised | 140,260 | ' |
Forfeited | 974 | ' |
Expired | 2,393 | ' |
Outstanding at December 31, 2013 | 4,040,531 | ' |
Exercisable | 4,019,980 | 5,715,146 |
Weighted Average Exercise Price | ' | ' |
Outstanding at September 30, 2013 | $13.08 | ' |
Exercised | $8.47 | ' |
Forfeited | $20.04 | ' |
Expired | $17.46 | ' |
Outstanding at December 31, 2013 | $13.23 | ' |
Exercisable | $13.23 | $11.54 |
Weighted Average Remaining Contractual Term | ' | ' |
Outstanding at December 31, 2013 | '2 years 8 months | ' |
Exercisable | '2 years 8 months | '2 years 11 months |
Aggregate Intrinsic Value | ' | ' |
Outstanding at December 31, 2013 | $9.80 | ' |
Exercisable | $9.70 | $61.60 |
StockBased_Compensation_Summar1
Stock-Based Compensation (Summary of Stock Options Activity) (Parenthetical) (Detail) (USD $) | 3 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Share-based Compensation [Abstract] | ' | ' |
Closing market value of common stock | $15.20 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value | $1.20 | $5.20 |
StockBased_Compensation_Summar2
Stock-Based Compensation (Summary of Activity Relating to Restricted Units) (Detail) (USD $) | 3 Months Ended |
In Millions, except Share data, unless otherwise specified | Dec. 31, 2013 |
Restricted Stock Awards | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' |
Purchase price for restricted units, vested | $0.00 |
Restricted Units, Outstanding [Roll Forward] | ' |
Outstanding at September 30, 2013 | 1,000,000 |
Granted | 250,000 |
Earned/released | 250,000 |
Forfeited | 0 |
Outstanding at December 31, 2013 | 1,000,000 |
Weighted average remaining recognition period of outstanding Restricted Units | '1 year 7 months |
Unearned stock-based compensation expense of outstanding Restricted Units | $19.70 |
Aggregate intrinsic value of outstanding Restricted Units | 15.2 |
Number of Shares Underlying Restricted Units — Contingent Awards | ' |
Restricted Units, Outstanding [Roll Forward] | ' |
Outstanding at September 30, 2013 | 5,587,181 |
Granted | 1,404,938 |
Earned/released | 745,689 |
Forfeited | 1,289,490 |
Outstanding at December 31, 2013 | 4,956,940 |
Weighted average remaining recognition period of outstanding Restricted Units | '2 years 0 months |
Unearned stock-based compensation expense of outstanding Restricted Units | 75.1 |
Aggregate intrinsic value of outstanding Restricted Units | 75.3 |
Number of Shares Underlying Restricted Units — Time-Based Awards | ' |
Restricted Units, Outstanding [Roll Forward] | ' |
Outstanding at September 30, 2013 | 9,095,424 |
Granted | 3,605,109 |
Earned/released | 3,242,497 |
Forfeited | 195,182 |
Outstanding at December 31, 2013 | 9,262,854 |
Weighted average remaining recognition period of outstanding Restricted Units | '1 year 11 months |
Unearned stock-based compensation expense of outstanding Restricted Units | 131.2 |
Aggregate intrinsic value of outstanding Restricted Units | $140.90 |
StockBased_Compensation_Summar3
Stock-Based Compensation (Summary of Activity Relating to Restricted Units) (Parenthetical) (Detail) (USD $) | Dec. 31, 2013 |
Share-based Compensation [Abstract] | ' |
Closing market value of common stock | $15.20 |
StockBased_Compensation_Summar4
Stock-Based Compensation (Summary of Weighted-Average Grant-Date Fair Value and Intrinsic Value of Restricted Units Vested) (Detail) (USD $) | 3 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Restricted Stock Units | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Weighted-average grant-date fair value per share | $14.59 | $22.25 |
Total intrinsic value of shares vested (in millions) | $59 | $100.90 |
Restricted Stock Awards | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Weighted-average grant-date fair value per share | $15.71 | ' |
StockBased_Compensation_StockB
Stock-Based Compensation Stock-Based Compensation (Restricted Stock Awards) (Details) (USD $) | 3 Months Ended | 3 Months Ended | |||||
In Millions, except Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Sep. 30, 2013 | Dec. 31, 2013 |
Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock Units | Restricted Stock Units | Restricted Stock Awards | Restricted Stock Awards | Number of Shares Underlying Restricted Units — Contingent Awards | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | ' | ' | ' | ' | $21.54 | $24.06 | ' |
Outstanding at September 30, 2013 | ' | ' | ' | ' | 1,000,000 | ' | 5,587,181 |
Number of Shares Underlying Restricted Stock, Granted | ' | ' | ' | ' | 250,000 | ' | 1,404,938 |
Number of Shares Underlying Restricted Stock, Vested | ' | ' | ' | ' | 250,000 | ' | 745,689 |
Outstanding at December 31, 2013 | ' | ' | ' | ' | 1,000,000 | ' | 4,956,940 |
Weighted average remaining recognition period of outstanding Restricted Units | ' | ' | ' | ' | '1 year 7 months | ' | '2 years 0 months |
Unearned stock-based compensation expense of outstanding Restricted Units | ' | ' | ' | ' | $19.70 | ' | $75.10 |
Aggregate intrinsic value of outstanding Restricted Units | ' | ' | ' | ' | 15.2 | ' | 75.3 |
Weighted Average Grant Date Fair Value, Granted | $15.71 | $22.32 | $14.59 | $22.25 | $15.71 | ' | ' |
Weighted Average Grant Date Fair Value, Vested | ' | ' | ' | ' | $25.80 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | ' | ' | ' | ' | 0 | ' | -1,289,490 |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Intrinsic Value | $3.90 | $5.30 | $59 | $100.90 | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | ' | ' | ' | ' | $0 | ' | ' |
Income_Taxes_Components_of_Ben
Income Taxes (Components of Benefit from Income Taxes) (Detail) (USD $) | 3 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Income Tax Disclosure [Abstract] | ' | ' |
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | ($5,200,000) | ' |
Domestic Tax Expense (Benefit) | -1,455,000 | -16,488,000 |
Foreign | 4,433,000 | 7,927,000 |
Provision (benefit) from income taxes | $2,978,000 | ($8,561,000) |
Effective tax rate | -5.70% | 27.90% |
Income_Taxes_Additional_Inform
Income Taxes (Additional Information) (Detail) (USD $) | 3 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2013 | |
Business Acquisition [Line Items] | ' | ' | ' |
Income taxes associated with uncertain tax position | $20,100,000 | ' | $19,600,000 |
U.S. federal statutory income tax rate | 35.00% | ' | ' |
Effective tax rate | -5.70% | 27.90% | ' |
Provision (benefit) from income taxes | $2,978,000 | ($8,561,000) | ' |
Commitments_and_Contingencies_
Commitments and Contingencies (Details) | 3 Months Ended |
Dec. 31, 2013 | |
Commitments and Contingencies Disclosure [Abstract] | ' |
Indemnification term for former officers and directors | '6 years |
Segment_and_Geographic_Informa2
Segment and Geographic Information and Significant Customers (Additional Information) (Detail) | 3 Months Ended |
Dec. 31, 2013 | |
Segment | |
Segment Reporting [Abstract] | ' |
Number of reportable business segments | 4 |
Segment_and_Geographic_Informa3
Segment and Geographic Information and Significant Customers (Segment Results Along with Reconciliation of Segment Profit to Income Before Income Taxes) (Detail) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Segment Reporting Information [Line Items] | ' | ' |
Revenue | $490,045 | $492,417 |
Revenues | 469,980 | 462,268 |
Segment profit | 135,716 | 173,690 |
Corporate expenses and other, net | -31,206 | -30,137 |
Acquisition-related revenues and cost of revenues adjustment | -18,832 | -27,666 |
Stock-based compensation | -47,239 | -45,271 |
Amortization of intangible assets | -42,666 | -41,736 |
Acquisition-related costs, net | -2,798 | -15,733 |
Restructuring and other charges, net | -3,837 | -1,667 |
Costs associated with IP collaboration agreements | -4,937 | -5,250 |
Other expense, net | -36,636 | -36,887 |
Loss before income taxes | -52,435 | -30,657 |
Healthcare | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Revenue | 227,286 | 217,374 |
Segment profit | 78,460 | 89,135 |
Mobile and Consumer | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Revenue | 115,262 | 131,731 |
Segment profit | 13,442 | 39,826 |
Enterprise | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Revenue | 89,202 | 83,696 |
Segment profit | 21,134 | 21,669 |
Imaging | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Revenue | 58,295 | 59,616 |
Segment profit | 22,680 | 23,060 |
Acquisition-related revenues | ' | ' |
Segment Reporting Information [Line Items] | ' | ' |
Revenues | ($20,065) | ($30,149) |
Segment_and_Geographic_Informa4
Segment and Geographic Information and Significant Customers (Classification of Revenue by Major Geographic Areas) (Detail) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Revenue | $490,045 | $492,417 |
Total revenues | 469,980 | 462,268 |
UNITED STATES | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Revenue | 343,185 | 340,288 |
International [Member] | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Revenue | $126,795 | $121,980 |